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Abstract
Cardiovascular disease (CVD) is the leading cause of death globally. One of the most 
effective forms of prevention and treatment is physical activity. However, recent studies 
have suggested that resistance exercise can increase arterial stiffness. Maintaining adequate 
strength is critical for performing activities of daily living, occupational-related tasks, and 
sport movements. The purpose of this project was to determine if novel combinations of 
resistance and aerobic exercise could offer musculoskeletal benefits without adverse 
cardiovascular consequences. In Study 1, we examined the effect of order (i.e. aerobic 
before resistance, or resistance before aerobic) on arterial stiffness when combining these 
exercise modes in a single training session. In Study 2, we compared the effects of acute 
eccentric and concentric arm cycling on central and peripheral arterial stiffness. Eccentric 
arm cycling is a unique combination of resistance and aerobic exercise. We hypothesized 
that these novel combinations of resistance and aerobic exercise would not cause arterial 
stiffening as observed in resistance exercise alone. In Study 1, we concluded performing 
resistance before aerobic to be the more beneficial exercise order in terms of arterial 
stiffness. In Study 2, we found that eccentric arm cycling reduces arterial stiffness in the 
arm, but not centrally. Collectively, our results suggest that the key to reducing the negative 
effects of resistance exercise on arterial function is to combine it with aerobic exercise, 
either first within a single session or simultaneously. 
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1 Literature Review 
The literature review of this thesis will provide a general framework to better 
understand the effects of combined resistance and aerobic exercise on arterial function. 
First, an overview of cardiovascular health will provide context to the burden of 
cardiovascular disease and the importance of preventative behaviors. Then, the utility of 
arterial stiffness an indicator of cardiovascular health will be defined. Additionally, specific 
measurement techniques used to assess arterial stiffness will be explained. The 
cardiovascular responses, with an emphasis on arterial stiffness, to different exercise 
modalities (aerobic, resistance, eccentric, and concentric) will be discussed. Finally, the 
current literature will be summarized in relation to the two presented research studies. 
1.1 Cardiovascular Health 
Cardiovascular disease (CVD) one of the largest health and economic burdens 
around the world (Mozaffarian et al., 2015). There are a variety of risk factors that influence 
the prevalence of CVD, such as: physical inactivity, hypertension, obesity, high blood 
lipids, diabetes mellitus, and family history (Mozaffarian et al., 2015). Although many 
agencies are working to reduce the prevalence of CVD, it only reduced modestly between 
1999 and 2012 (Booth et al., 2017).  
Increased physical activity is one behavioral modification that can be used to prevent 
CVD. Physical activity is associated with reducing the risk of CVD and all-cause mortality 
by nearly a third (Nocon et al., 2008). Physical activity and exercise can improve body 
composition and reduce other risk factors, such as blood pressure. This may be attributed 
to positive adaptations within the cardiovascular system, specifically changes to the 
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vasculature. Improvements in endothelium function and vascular remodeling have been 
observed following exercise training (Green, Maiorana, O'Driscoll, & Taylor, 2004), which 
can reduce stiffening of arteries.  
1.2 Arterial Stiffness 
Arterial stiffness occurs when arteries lose their ability to expand and recoil during 
the cardiac cycle. Degradation of the elastic fibers occurs naturally through aging, but other 
factors can either slow or quicken the process. Although there are genetic factors, lifestyle 
and pathologies (i.e. hypertension, diabetes mellitus, etc.) often contribute to arterial 
stiffness (Zieman, Melenovsky, & Kass, 2005). This can cause reflected pressure 
waveforms from bifurcations in the vasculature to return to the heart early, which then 
augments aortic blood pressure and potentially induces damage.  
1.2.1 Measurement Techniques 
Arterial stiffness can be assessed noninvasively through applanation tonometry in 
clinical and research settings. This technique involves placing a small pressure transducer 
onto a pulse site. The blood vessel is flattened against hard underlying tissue and the 
pressure waveform at the site is recorded. Pulse wave analysis (PWA) and pulse wave 
velocities (PWV) can be measured using this technique. 
The process of PWA includes estimating aortic pulse pressures based on the 
measured pressure waveform characteristics and a validated transfer function (Chen et al., 
1997). Augmentation index (AIx) can also be calculated by determining the percentage of 
aortic pulse pressure that is caused by a reflected waveform returning to the heart. AIx has 
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been shown to be directly related to arterial stiffness (Laurent et al., 2006). Heart rate can 
influence the value of AIx, therefore, it is best practice to normalize for the heart rate of 75 
beats per minute (AIx@75). Higher values of AIx@75 indicate increased systemic arterial 
stiffness. 
Arterial stiffness can also be assessed regionally using PWV. The process includes 
measuring two different pulse sites along region of interest (e.g. carotid and radial to assess 
the arm) and measuring their transit time by gating them to the R-wave of an 
electrocardiogram. Higher values of pulse wave velocity indicate increased arterial 
stiffness within that region. 
Although AIx and PWV are valuable measures of arterial stiffness, they are not 
interchangeable. One can be affected independently of the other (Kelly, Millasseau, Ritter, 
& Chowienczyk, 2001). AIx is influenced by integrity of smaller vasculature, whereas 
PWV is primarily a result of the elasticity of large arteries (Kelly et al., 2001). Measures 
of AIx and PWV can be taken at rest or pre and post interventions (e.g. exercise) to 
determine changes in arterial function. 
1.3 Cardiovascular Responses to Exercise 
The cardiovascular system serves a key role in maintaining homeostasis within the 
human body. Physical activity is one of the most common everyday stressors that stimulate 
the system to respond. In order to meet the increased metabolic demand to sustain activity, 
heart rate and blood pressure throughout the vasculature become augmented in order to 
deliver required oxygen and nutrients to the active tissue. 
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The changes within the cardiovascular system are partially regulated by the nervous 
system. During moderately intense exercise, sympathetic neural activity is increased and 
parasympathetic neural activity is inhibited. The increase in sympathetic activity, increases 
cardiac output. In addition, vasoconstriction occurs within the active muscle mass to 
promote blood flow. Systolic blood pressure increases linearly with dynamic exercise 
intensity and diastolic tends to decrease (Laughlin, 1999). In contrast, resistance exercise 
typically causes larger increases in pulse pressure that are oscillatory and dependent on the 
phase of the exercise (Laughlin, 1999).   
Although the changes induced by exercise are well understood, different types of 
exercise elicit different responses. Therefore, measuring and understanding these 
physiological differences is important when prescribing exercise, especially in clinical 
populations.  
1.3.1 Aerobic Training 
Aerobic training involves physical activity activities such as walking, running, 
cycling, and swimming. It is activity that can be sustained for extended periods of time 
while consuming oxygen to meet the energy demands. A recent meta-analysis concluded 
that chronic aerobic exercise training improved both AIx and PWV significantly (Ashor, 
Lara, Siervo, Celis-Morales, & Mathers, 2014). Moreover, another meta-analysis found 
that aerobic exercise had very little acute effects on arterial stiffness (Pierce, Doma, & 
Leicht, 2018). However, the results of this meta-analysis did note significant diversity 
within the aerobic exercise studies. Studies that have examined direct differences between 
aerobic and resistance exercise suggest that aerobic exercise provides a more beneficial 
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stimulus to the cardiovascular system. (Collier et al., 2010; Heffernan, Collier, Kelly, Jae, 
& Fernhall, 2007). 
1.3.2 Resistance Training 
In contrast to aerobic training, the effects of resistance exercise on arterial stiffness 
have been debated. One meta-analysis of 42 randomized, controlled studies found that 
resistance training had no effect on arterial stiffness (Ashor et al., 2014). Likewise, another 
review of 17 randomized controlled studies reported that resistance exercise did not 
augment arterial stiffness (Li, Hanssen, et al., 2015). In contrast, an earlier meta-analysis 
of eight randomized controlled clinical trials found that resistance training actually 
increased arterial stiffness (Miyachi, 2013). 
Although there have been contrasting findings from studies on the effects of chronic 
resistance exercise, a recent meta-analysis of 45 acute exercise studies concluded that both 
carotid-femoral PWV and AIx increases following resistance exercise (Pierce et al., 2018).  
1.3.3 Eccentric v. Concentric Training 
Few studies have examined at the different muscle actions of resistance exercises: 
concentric (i.e. muscle shortening) and eccentric (i.e. active muscle lengthening). One 
controlled training study assessed the brachial-ankle pulse wave velocity after 8 weeks of 
either concentric resistance training, eccentric resistance training, or remaining sedentary 
(Okamoto, Masuhara, & Ikuta, 2006b). All three groups had similar pre-training values. 
However, after training, only the concentric resistance training participants increased their 
arterial stiffness. Likewise, one of our recent training studies reported no change in radial-
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carotid or carotid-femoral pulse wave velocity after dynamic eccentric arm exercise (Elmer 
et al., 2017). This suggested that eccentric exercise may be a safe form of resistance 
exercise in terms of cardiovascular health. 
1.4 Summary and Hypothesis  
Exercise is one the leading methods to prevent and treat CVD (Patnode, Evans, 
Senger, Redmond, & Lin, 2017). However, some modalities of exercise can negatively 
impact the cardiovascular system by eliciting stiffening of the elastic arteries. Although 
there is some debate, it appears that concentric resistance exercise can have harmful acute 
cardiovascular consequences (Pierce et al., 2018). However, the negative effects of 
resistance may be able to be negated by combining aerobic exercise or isolating eccentric 
muscle contractions within the resistance exercise.  
Study 1 examines the effect of order (i.e. aerobic before resistance (AR) or resistance 
before aerobic (RA)) on arterial stiffness when combining these exercise modes in a single 
training session. Study 2 compares the effects of acute eccentric and concentric arm cycling 
on central and peripheral arterial stiffness. We hypothesized that these novel combinations 
of resistance and aerobic exercise would not cause arterial stiffening as observed in 
resistance exercise alone. 
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2 Study 1: The Influence of Resistance and Aerobic 
Exercise Order on Acute Arterial Stiffness Responses 
2.1 Introduction 
Both aerobic and resistance exercise are frequently used to improve health. Although 
individuals may focus primarily on one mode or the other, combining both methods has 
been cited as one of the most effective way to manage body composition and improve 
overall fitness (Donnelly et al., 2009). Furthermore, in the interest of time and convenience, 
it is common for individuals to mix these training methods into the same exercise session. 
Both aerobic and resistance exercise have been shown to influence arterial stiffness. 
Chronically, aerobic exercise training is thought to reduce arterial stiffness, while 
resistance exercise is thought to increase it (Miyachi et al., 2004). Aerobic exercise has 
been observed to reduce arterial stiffness acutely (Collier et al., 2010; Heffernan, Collier, 
et al., 2007), while resistance exercise may acutely increase stiffness (DeVan et al., 2005). 
A single acute session of aerobic exercise is reported to decrease arterial stiffness for up to 
60 minutes post-exercise (Heffernan, Collier, et al., 2007). 
Although the acute and chronic effects of independent aerobic and resistance 
exercise on arterial stiffness are known, the acute effects of performing both modes in a 
single session remain unclear. One study reports that arterial stiffness is reduced after eight-
weeks of resistance then aerobic training, but not after aerobic then resistance training 
(Okamoto, Masuhara, & Ikuta, 2007). However, it is unknown whether the order in which 
these exercise modes are performed within a session has an effect on post-exercise arterial 
stiffness. Therefore, we hypothesized that arterial stiffness would be lower following 
resistance then aerobic (RA), but not after aerobic then resistance (AR) exercise. 
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2.2 Methods 
2.2.1 Subjects 
Seventeen (12 male, 5 female) healthy, recreationally active individuals participated 
in the study as shown in Table 1. All participants reported to not smoke, take any 
heart/blood pressure medications, or have a pacemaker. All participants attended an 
orientation session before providing written informed consent. A physical activity 
readiness questionnaire was also completed with each participant before testing. This study 
was reviewed and approved by the Michigan Technological University Institutional 
Review Board. 
Table 1: Participant demographics, anthropometrics, and resting seated cardiovascular 
values. 
2.2.2 Experimental Design 
Two testing sessions were performed, one in which participants performed a bout of 
RA exercise, and one where the opposite order was performed (i.e. AR). Each mode of 
exercise was performed for 30 minutes, so that the total exercise duration per session was 
60 minutes. All participants completed both testing sessions approximately one week apart 
in a randomized balanced crossover design. Prior to each testing session, participants 
abstained from alcohol, caffeine, and exercise for a minimum of 12 hours, and fasted for 
at least 3 hours before. 
Age 
(year) 
Height 
(cm) 
Weight 
(kg) 
BMI 
(kg/m2) 
SAP 
(mmHg) 
DAP 
(mmHg) 
MAP 
(mmHg) 
HR 
(bpm) 
24 ± 2 174 ± 2 78 ± 3 25 ± 1 118 ± 3 65 ± 3 83 ± 2 59 ± 2 
Values are reported as mean ± standard error. Body mass index (BMI), systolic 
arterial pressure (SAP), diastolic arterial pressure (DAP), mean arterial pressure 
(MAP), and heart rate (HR). 
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Figure 1: Conceptual diagram describing the protocol for each testing session. 
2.2.3 Resistance Training 
Resistance exercise training consisted of three sets of ten repetitions for six exercises, 
with each separated by one minute of rest. The exercises were performed in the following 
order: barbell squat, barbell bench press, seated lat pull down, triceps pushdown, biceps 
curls, and single leg lunge. The load for the each exercise was set at each participant’s ten-
repetition max, which was measured during the orientation session. The same load was 
used for both RA and AR exercise sessions. Resistance training duration averaged 30 
minutes, with a range of 28 to 32 minutes.  
2.2.4 Aerobic Training 
Aerobic exercise training was conducted using a treadmill. Participants were able to 
self-select the speed and grade in order to maintain approximately 70% of their age-
predicted maximum heart rate for 30 minutes to match the intensity and time of the 
resistance training. The same speed and grade was used for the RA and AR exercise 
sessions. 
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2.2.5 Measurements 
During each testing session, measurements were taken at pre-exercise, mid-exercise 
(in between the two modes of exercise), directly after the exercise session, and 30 minutes 
post-exercise. The pre-exercise brachial blood pressures were taken in triplicate after at 
least 10 minutes of supine rest with an automated cuff (Omron HEM-907XL, Omron 
Health Care, Vernon Hills, IL) with one minute between each recording. A single supine 
blood pressure was taken at mid, post, and 30 minutes post-exercise. 
The brachial blood pressures were used to calibrate the SphygmoCor CPVH system 
(AtCor Medical, West Ryde, Australia) for pulse wave analysis (PWA) measurements. A 
small pressure transducer (Milar Instruments, Houston, TX) was placed at the radial pulse 
site to record ten consecutive waveforms to estimate the aortic augmentation index and 
aortic blood pressure. These PWA measurements were performed in duplicate at each of 
the time points outlined above.  
Peripheral pulse wave velocity (pPWV) was measured from waveforms at the radial 
and carotid pulses to observe arm arterial stiffness. Central pulse wave velocity (cPWV) 
was measured from waveforms at the carotid and femoral pulses to observe trunk arterial 
stiffness. The waveforms were gated to the R-wave of a three-lead electrocardiogram 
recording, which was also used to obtain heart rate (HR). Distances between the 
suprasternal notch, carotid pulse, radial pulse, and femoral pulse sites were measured as 
straight lines with a tape measure. Recordings were completed in duplicate following 
recommendations from the American Heart Association (Townsend et al., 2015). Aortic 
pulsatile load was calculated by multiplying aortic pulse pressure by the heart rate derived 
from the SphygmoCor system. 
11 
2.2.6 Statistical Analysis 
Paired t-tests were used to test for differences in resting physiological values between 
to the two trials. A 2 (exercise order) x 4 (time) repeated measures analysis of variance 
(ANOVA) was used to assess difference in heart rate, mean arterial pressure, aortic 
pulsatile load, and pulse wave velocities (pPWV and cPWV). Post-hoc paired t-tests were 
performed when a significant time effect or condition (i.e. exercise order) by time 
interaction were observed after the ANOVA procedures. Data are presented as mean ± 
standard error and the a priori alpha was set to 0.05. 
2.3 Results 
Heart rate, mean arterial pressure, pPWV, and cPWV values were similar at rest 
before both exercise order conditions as shown in Table 2. Aortic pulsatile load was slightly 
higher preceding the AR than the RA condition. 
Table 2: Baseline values between two testing sessions. 
Heart rate increases were similar (time effect: P < 0.05) for RA and AR. Heart rate 
increased during exercise and remained elevated afterwards in both conditions. (57 ± 2 vs. 
57 ± 2, 89 ± 5 vs. 92 ± 3, 97 ± 3 vs. 100 ± 4, and 74 ± 3 vs. 79 ± 4, time effect: P = 0.00). 
Mean arterial pressure increased significantly during exercise, but returned to baseline 30 
Variable RA Session AR Session P value 
Heart Rate (bpm) 57 ± 2 57 ± 3 0.54 
MAP (mmHg) 81 ± 2 81 ± 2 0.97 
Peripheral PWV (m/s) 7.3 ± 0.3 7.3 ± 0.3 1.00 
Central PWV (m/s) 5.8 ± 0.3 5.6 ± 0.2 0.48 
Values are reported as mean ± standard error. Mean arterial pressure (MAP), pulse 
wave velocity (PWV). 
12 
minutes post-exercise during the RA session (81 ± 2 vs. 79 ± 2 mmHg, P = 0.38) and was 
reduced after the AR session (81 ± 2 vs. 74 ± 2 mmHg, P < 0.05). Aortic pulsatile load 
increased during exercise and remained elevated post-exercise after both sessions (P < 0.05 
for both) as depicted in Figure 1. 
 Arm arterial stiffness (i.e., pPWV) tended to decrease 30 minutes after both RA 
and AR sessions (7.4 ± 0.3 vs. 6.9 ± 0.3; 7.2 ± 0.3 vs. 6.9 ± 0.3 m/s, time effect: P = 0.086). 
Aortic arterial stiffness (i.e. cPWV) decreased similarly 30 minutes after both RA and AR 
sessions (5.8 ± 0.3 vs. 5.5 ± 0.2; 5.6 ± 0.2 vs. 5.5 ± 0.2 m/s, time effect: P < 0.05). When 
normalized to aortic mean arterial pressure, cPWV values were increased following the AR 
session (0.072 ± 0.002 vs. 0.078 ± 0.003 m/s/mmHg, P < 0.05). 
 
z 
Figure 2: Aortic pulsatile load (aPL) before, between, and after exercise. Time effect: P < 
0.05  
 
* 
* * 
* 
* 
* 
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Figure 3: Peripheral (Panel A), central (Panel B), and normalized central (Panel C) pulse 
wave velocity responses 30 min post-exercise. * P < 0.05 vs. order 
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2.4 Discussion 
This is the first study to report the effect of the order of aerobic and resistance 
exercise on acute cardiovascular responses. Heart rate changed and recovered similarly for 
each exercise order (i.e. RA and AR). Likewise, aortic pulsatile load increased and 
remained elevated after each session similarly. After both RA and AR, pPWV tended to be 
reduced 30 minutes post. There was a similar reduction in cPWV after each order. 
However, when normalized to mean aortic blood pressure, cPWV appears to be elevated 
following AR.  
Prolonged elevated aortic pulse pressure and / or heart rate can increase pulsatility to 
pressure sensitive end organs, such as the brain and the kidney (Augustine, Yoon, Choo, 
Heffernan, & Jae, 2016). In the present study, aortic pulsatile load remained elevated 30 
minutes post-exercise for both the RA and AR conditions. Although this elevation is not 
likely to cause long-term damage, it is important to consider in future chronic training 
studies and clinical populations. It would be interesting to determine if pulsatile load is 
reduced to baseline conditions more rapidly following RA or AR. 
Peripheral and central arteries are structurally and functionally different, and 
therefore may respond to exercise differently. The peripheral vasculature can vasodilate in 
active tissue and vasoconstrict in other areas during resistance exercise, whereas aerobic 
exercise typically induces whole body vasodilation (Sardeli, Gaspari, & Chacon-Mikahil, 
2015). Vasodilation during exercise can increase shear stress and nitric oxide 
bioavailability, which in turn can decrease regional arterial stiffness (Beck, Casey, Martin, 
Emerson, & Braith, 2013; C. Goto et al., 2003). Arterial stiffness in the arms, as measured 
by pPWV in our study, tended to decrease after each session. The tendency for reductions 
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in pPWV may have been due to vasoactive substances, such as nitric oxide, similar to 
previous work by Beck, Martin, Casey, and Braith (2013). Moreover, this reduction in 
pPWV is likely associated with our study protocol, which included four upper-body 
resistance exercises (Fahs, Heffernan, & Fernhall, 2009).  
Although cPWV is considered the gold standard for measuring arterial stiffness 
(Laurent et al., 2006), cPWV is a pressure-dependent measure. Therefore, normalizing 
cPWV to aortic mean pressure, can be useful when interpreting results from an exercise 
intervention (Sacre, Jennings, & Kingwell, 2014). Our acute normalized cPWV results 
suggest that RA may be a better option for combined exercise compared to AR. Results 
from an 8-week combined training study reported that performing resistance then aerobic 
exercise can reduce arterial stiffness (Okamoto et al., 2007). Importantly, the above 
benefits were lost with four weeks of detraining (Okamoto et al., 2007), signifying the 
importance of consistence acute bouts of combined exercise. Furthermore, early studies 
noted improved growth hormone (K. Goto, Higashiyama, Ishii, & Takamatsu, 2005) and 
greater lipolysis (K. Goto, Ishii, Sugihara, Yoshioka, & Takamatsu, 2007) when resistance 
exercise is performed before aerobic exercise. More recently, this order of combined 
training has also been shown to be beneficial in diabetics by improving glycemic stability 
(Yardley et al., 2012) and increasing growth hormone secretion (Yardley, Sigal, Riddell, 
Perkins, & Kenny, 2014) throughout the exercise session. 
One limitation to this study is that the sample size did not allow us to adequately 
examine potential sex differences. Our sample had a larger percentage of male participants 
(12 male, 5 female). It has been previously reported that there can be differences in arterial 
stiffness at rest and after acute bouts of exercise between males and females (Doonan, 
16 
Mutter, Egiziano, Gomez, & Daskalopoulou, 2013). Understanding these potential 
differences is important for future exercise prescription recommendations. 
In conclusion, although there is much debate of the effects of resistance exercise on 
arterial stiffness, and a recent meta-analysis concluded that acute resistance exercise is 
likely to have adverse effects on arterial stiffness (Pierce et al., 2018). Conversely, aerobic 
exercise was reported to reduce pulse wave velocity (Pierce et al., 2018). However, it has 
been demonstrated in a cross-sectional study that simultaneous resistance and aerobic 
exercise (i.e. rowing) can be used to reduce stiffening (Cook et al., 2006). Our results in 
the present study also suggest that by combining both forms of exercise within a single 
exercise session can also reduce stiffening independent of exercise order. However, our 
results regarding cPWV normalized to aMAP, in conjunction with previous work on 
arterial stiffness (Okamoto et al., 2007) and metabolic function (K. Goto et al., 2005; K. 
Goto et al., 2007; Yardley et al., 2012; Yardley et al., 2014), may suggest that RA would 
be the most beneficial combined exercise order. 
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3 Study 2: Post-Exercise Arterial Stiffness Responses 
Are Similar After Acute Eccentric and Concentric Arm 
Cycling 
3.1 Introduction 
Many activities of daily living, work-related manual labor, and locomotor tasks such 
as wheelchair propulsion rely on arm, shoulder, and trunk musculature. Adequate upper-
body strength is critical for maintaining health, functioning independently, and preventing 
lifestyle related diseases (P. LaStayo, Marcus, Dibble, Frajacomo, & Lindstedt, 2014).  
However, both acute (Pierce et al., 2018) and chronic (Miyachi et al., 2004) resistance 
exercise can increase arterial stiffness. Additionally, upper-body resistance exercise has 
been observed to increase arterial stiffness both acutely (Li, Bopp, et al., 2015) and 
chronically (Okamoto, Masuhara, & Ikuta, 2009) to a greater extent than lower-body 
resistance exercise. Increased stiffness (inability to expand and recoil during the cardiac 
cycle) of arteries contributes to hypertension (Carthy, 2014), and increases the risk for 
cardiovascular disease (Vlachopoulos, Aznaouridis, & Stefanadis, 2010). In contrast to 
upper-body resistance exercise, upper-body aerobic exercise provides cardiorespiratory 
benefits and can acutely decrease regional (i.e. arm) arterial stiffness (Ranadive et al., 
2012).  
Resistance exercise typically includes both concentric (active muscle shortening) and 
eccentric (active muscle lengthening) phases. Forces produced during eccentric muscle 
actions can be substantially greater than those produced during concentric muscle actions 
(P. C. LaStayo, Pierotti, Pifer, Hoppeler, & Lindstedt, 2000). In addition to this increased 
capacity for force production, eccentric exercise is performed with a lower metabolic cost 
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and thus lower perceived exertion (Elmer, Danvind, & Holmberg, 2013; Elmer & LaStayo, 
2014; Elmer, Marshall, McGinnis, Van Haitsma, & LaStayo, 2013). To date, it is well 
established that eccentric exercise is more effective than traditional concentric-based 
exercise at improving neuromuscular function (Elmer et al., 2017), balance, and mobility 
in populations ranging from cardiopulmonary patients to competitive athletes  (Isner-
Horobeti et al., 2013; P. LaStayo et al., 2014). 
During eccentric exercise sympathetic activation and blood pressure are lower 
compared to similarly matched concentric exercise (Carrasco, Delp, & Ray, 1999). These 
attributes would possibly favor lower post-exercise arterial stiffness outcomes. In related 
work, Okamoto and colleagues  reported that eight weeks of eccentric elbow flexor actions 
increased strength without changing arterial stiffness, whereas concentric elbow flexor 
actions increased strength and arterial stiffness (Okamoto, Masuhara, & Ikuta, 2006a). 
These results are promising and imply that attenuated circulatory adjustments to eccentric 
muscle action might help to offset the effects of arterial stiffening associated with 
resistance exercise. With this in mind, we sought to determine whether a novel form of 
upper-body resistance cycling exercise could be performed without compromising arterial 
function. 
We recently developed a novel eccentric arm cycle ergometer in which the user 
resists the reverse moving motor-driven handles (Figure 3). This modality can be used to 
safely perform repetitive, high-force, multi-joint eccentric actions with the upper-body 
while minimizing metabolic and cardiorespiratory strain. Assessment of arterial stiffness 
following acute eccentric and concentric arm cycling performed at the same heart rate 
would offer a model for evaluating the impact of aerobically-based upper-body resistance 
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exercise on arterial function. Accordingly, the purpose of this study was to compare the 
effects of acute eccentric and concentric arm cycling on central and peripheral arterial 
stiffness. We anticipated that power output during eccentric arm cycling would be ~2x 
greater than that during concentric arm cycling (Elmer, Danvind, et al., 2013). Previous 
work has shown that regional arterial stiffness is reduced after acute arm and leg cycle 
ergometry, but that central arterial stiffness remains unchanged (Ranadive et al., 2012). 
Therefore, we hypothesized that peripheral arterial stiffness would be reduced following 
both eccentric and concentric arm cycling, but that that central arterial stiffness would 
remain unchanged.  
3.2 Methods 
3.2.1 Participants 
 Twenty-two healthy individuals volunteered to participate in this study. Seventeen 
of these participants were part of a previously published training study (Elmer et al., 2017). 
Participants were recreationally active, but did not regularly participate in upper-body 
aerobic or resistance exercise. Experimental procedures used in this investigation were 
reviewed and approved by the Michigan Technological University Institutional Review 
Board. The protocol and procedures were explained verbally and all participants provided 
written informed consent prior to testing.  Participants were clustered together in such a 
way as to create two exercise groups of 11 participants with similar body composition, 
upper-body cardiorespiratory capacity, and maximum upper-body muscular power as 
shown in Table 1. 
 
20 
Table 3: Participant demographic, anthropometric, and physiological characteristics. 
Variable Eccentric  (n = 11) 
Concentric  
(n = 11) P value 
Age (yr)  23 ± 1 24 ± 1 0.53 
Height (m) 1.74 ± 0.03 1.77 ± 0.03 0.60 
Body mass (kg) 74 ± 4 79 ± 5 0.40 
BMI (kg∙m-2) 24 ± 1 25 ± 1 0.58 
Body Fat (%) 22 ± 4 25 ± 4 0.62 
Systolic Arterial 
Pressure (mmHg) 110 ± 4 111 ± 3 0.86 
Diastolic Arterial 
Pressure (mmHg) 60 ± 3 61 ± 2 0.86 
Resting Heart Rate 
(b∙min-1) 64 ± 3 60 ± 3 0.33 
V̇O2peak (L∙min-1) 2.2 ± 0.2 2.3 ± 0.2 0.74 
V̇O2peak (ml∙kg-1∙min-1)  29 ± 3 29 ± 2 0.82 
HRpeak (b∙min-1)  185 ± 3 181 ± 3 0.37 
Wpeak (W)  134 ± 12 134 ± 12 1.00 
Pmax (W)  599 ± 59 591 ± 60 0.94 
Values are reported as Mean ± SE. Body mass index (BMI), peak oxygen 
consumption (VO2peak), peak heart rate ( HRpeak), peak power reached at the 
end of  VO2peak test (Wpeak), and maximal upper-body concentric power ( Pmax). 
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3.2.2 Pre-Experimental Assessments 
Body composition was assessed using dual energy x-ray absorptiometry (DEXA; 
Lunar Prodigy, General Electric Company, Fairfield, CT, USA). Upper-body 
cardiorespiratory capacity was evaluated during an incremental concentric arm cycling test 
(15 + 15 W·min-1) using an expired air analysis system (ParvoMedics TrueOne 2400, Salt 
Lake City, UT, USA) for determination of peak oxygen consumption (V̇O2peak), peak heart 
rate (HRpeak), and peak power output reached (Wmax). Maximum upper-body power was 
determined during maximal concentric arm cycling trials (3 s, 120 rpm). Exercise groups 
were then assigned to one of the following exercise conditions: 1) eccentric arm cycling, 
or 2) concentric arm cycling. 
3.2.3 Habituation Period 
During the weeks preceding the experimental visit, participants in the eccentric group 
performed several habituation trials of eccentric arm cycling in order become familiar with 
the cycle ergometer, acquire the specific coordination required for eccentric arm cycling, 
and minimize the occurrence of muscle soreness that can be associated with unaccustomed 
eccentric exercise (P. C. LaStayo et al., 2000). Participants in the concentric group also 
performed similar habituation sessions of concentric arm cycling. Muscle soreness 
associated with eccentric arm cycling or concentric arm cycling was monitored using a 
visual analog scale (0-10 cm; 10 cm representing the most soreness possible (Elmer, 
Marshall, et al., 2013; P. C. LaStayo et al., 2000)). Specifically, 24 to 48 hours after each 
habituation trial, participants performed a standardized bilateral elbow extension 
movement (‘‘bench dip’’) during which they indicated the level of perceived muscle 
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soreness in their arms by placing a mark on the visual analog scale. Perceived muscle 
soreness was quantified by measuring the distance to the mark on the line to the nearest 0.1 
cm. Both groups tolerated the habituation sessions well as muscle soreness was minimal 
(< 1.0 cm), and thus were reasonably trained with their respective modality. 
3.2.4 Experimental Protocol 
For the experimental visit, participants were instructed to avoid exercise and caffeine 
for 12 h preceding the experiment which was performed at least 3 h post-prandial. Baseline 
measures of heart rate, blood pressure, and pulse wave velocity were recorded before 
exercise (described below). Subsequently, participants performed either eccentric arm 
cycling or concentric arm cycling on an isokinetic arm cycle ergometer (described below) 
at ~70% of HRpeak for 20 min at a pedaling rate of ~60 rpm. Arm cycling power output and 
heart rate (Polar Electro OY, Kempele, Finland) were recorded and averaged over the 20 
min exercise trial. Overall rating of perceived exertion (RPEbody), as well as arm specific 
RPE (RPEarm), were assessed during the final min of exercise using a Borg 6-20 scale 
(Borg, 1982). Heart rate, blood pressure, and pulse wave velocity were reassessed at 10 
min and 30 post exercise. These time points were selected because previous studies have 
shown that arterial stiffness can be altered from 10 to 30 min post-exercise (Heffernan, Jae, 
Echols, Lepine, & Fernhall, 2007; Ranadive et al., 2012).  
3.2.5 Cardiovascular Parameters  
 All measurements were completed following the guidelines from the American 
Heart Association for standardizing vascular research (Townsend et al., 2015).  At baseline, 
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brachial blood pressures were taken in triplicate after at least 10 minutes of supine rest with 
an automated cuff (Omron HEM-907XL, Omron Health Care, Vernon Hills, IL) with one 
minute between each recording. Average systolic arterial pressure (SAP) and diastolic 
arterial pressure (DAP) were used to calibrate the SphygmoCor CPVH system (AtCor 
Medical, West Ryde, Australia) for pulse wave analysis measurements. A single supine 
blood pressure was taken to calibrate directly before recordings at 10 and 30 min post 
exercise.  
 A small pressure transducer (Millar Instruments, Houston, TX) was placed at the 
radial pulse site to record consecutive waveforms during pulse wave analysis. The 
SphygmoCor system was used to estimate aortic blood pressures and aortic augmentation 
index (AIx) from the radial site. Recordings were completed in duplicate with an operator 
index of ≥ 80 for all readings as recommended by the manufacturer. Values are reported as 
an average of the two recordings. Aortic pulsatile load was calculated by multiplying the 
average aortic pulse pressure by the heart rate from the SphygmoCor system. 
Peripheral pulse wave velocity (pPWV) was measured from waveforms at the radial 
and carotid pulses to indicate arm arterial stiffness. Central pulse wave velocity (cPWV) 
was measured from waveforms at the carotid and femoral pulses to indicate aortic arterial 
stiffness. The pressure waveforms were gated to the R-waves of a three-lead 
electrocardiogram recording, which was also used to obtain heart rate (HR). Distances 
between the suprasternal notch to the carotid, radial, and femoral pulse sites were measured 
as straight lines with a tape measure. Pulse wave velocity recordings were taken in 
duplicate with ≤ 10% standard error and a HR difference of ≤ 5 b∙min-1 between the 
consecutive measurements sites. Values are reported as an average of the two recordings. 
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3.2.6 Arm Cycle Ergometer 
The isokinetic arm cycle ergometer (Figure 1) used in this investigation has been 
previously described in detail (Elmer, Marshall, et al., 2013). Briefly, the flywheel of the 
ergometer was driven in reverse for eccentric arm cycling group by a 560 W three-phase 
electric motor (Leeson, C4T17PT2C; Santa Fe Springs, CA, USA) via pulleys and a belt, 
or driven forward by the participants in the concentric arm cycling group.  The motor was 
controlled by a variable frequency drive equipped with regenerative braking capability 
(Leeson, SM2 Series, Sante Fe Springs, CA, USA).  Power delivered to the ergometer 
crank was quantified using a power meter (Schoberer Rad Messtechnik, SRM, Jülich, 
Germany), which serves as an accurate method to quantify cycling power (Abbiss, Quod, 
Levin, Martin, & Laursen, 2009).  Pedaling rate was set to ~60 rpm and the SRM power 
meter (sampled at 2 Hz) displayed the power that the participant was absorbing (eccentric 
arm cycling trials) or producing (concentric arm cycling trials). The SRM power meter was 
calibrated using static calibration procedures (Elmer, Danvind, et al., 2013) and a zero 
offset (funloaded) was obtained before all arm cycling trials. The cranks (170 mm) were 
positioned in the asynchronous fashion and custom made wider surface area handles were 
used to allow for a comfortable pronated hand position. Ergometer seat position was 
carefully standardized such that the: 1) crank axle was set just below the level of the heart, 
2) elbow was positioned at a comfortable angle when the cranks were horizontal (~20° 
ulnar notch to humeral head), and 3) legs were positioned to help stabilize the torso (~90° 
lateral malleolus to greater trochanter). Finally, for the eccentric arm cycling trials, 
participants were instructed to "resist" the motor-driven handles of the ergometer at the 
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specified target heart rate whereas for the concentric arm cycling trials, participants were 
instructed to propel the handles of the ergometer at the specified target heart rate.  
 
Figure 4: Motor-driven ergometer for eccentric arm cycling. The handles are driven in a 
backwards rotation as indicated by the grey arrows, and the participant resists the turning 
of the handles as indicated by the black arrow. 
3.2.7 Data Analysis 
Independent t-tests were used to test for differences in participant demographic 
data, power output, heart rate, and RPE values between eccentric arm cycling and 
concentric arm cycling.  A 2 (exercise group) x 3 (time) repeated measures analysis of 
variance (ANOVA) was used to assess differences in heart rate, brachial blood pressures, 
aortic blood pressures, aortic augmentation index normalized to 75 b∙min-1 (AIx@75), and 
pulse wave velocity (cPWV, pPWV). If any of the ANOVA procedures revealed a 
significant time effect, and/or group x time interaction, then subsequent post-hoc tests were 
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performed to determine where those differences occurred.  Data are presented as mean ± 
standard error and the a priori alpha was set to 0.05. 
3.3 Results 
3.3.1 Responses during exercise 
Mechanical, cardiorespiratory, and perceptual responses to the 20 min exercise trial 
are reported in Figure 4. Power absorbed during eccentric arm cycling was ~2x that 
produced during concentric arm cycling (125 ± 13 vs. 67 ± 7 W, p < 0.01). These powers 
corresponded to 94 ± 5 and 50 ± 2% of the peak power reached during the concentric arm 
cycling VO2peak test (Wpeak) and to 22 ± 2 and 12 ± 1% of maximal concentric arm cycling 
power (Pmax), respectively. Mean absolute and relative heart rates during eccentric arm 
cycling (122 ± 4 b∙min-1, 66 ± 2% of HRpeak) and concentric arm cycling (122 ± 2 b∙min-1, 
67 ± 1% of HRpeak) did not differ (p = 0.87 and p = 0.68, respectively) and were close to 
the prescribed target of target of 70% of HRpeak. Rating of perceived exertion for the whole-
body during eccentric and concentric arm cycling was between a “light” and “somewhat 
hard” effort and did not differ between groups (12.6 ± 0.4 vs. 11.8 ± 0.5, p = 0.20). Rating 
of perceived exertion for the arms during eccentric and concentric arm cycling was between 
a “somewhat hard” and “hard” effort and did not differ between groups (14.0 ± 0.3 vs. 13.4 
± 0.6, p = 0.38).  
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Figure 5: Eccentric arm cycling results in significantly greater production of work and 
power at a predetermined heart rate (HR) as an absolute value or percentage of the 
participant’s age-predicted maximal value. Ratings of perceived exertion (RPE) were 
similar. * p<0.05 between groups 
3.3.2 Responses after exercise 
 Heart rate tended to be elevated at 10 min post ECCarm (p=0.08) and was elevated 
at 10 min post CONarm (p<0.01), but returned to baseline levels at 30 min post-exercise in 
both groups. Mean arterial pressure was not significantly changed from baseline at 10 or 
30 min post-exercise in either group. Aortic pulsatile load remained elevated 10 and 30 
min post exercise in both groups (p<0.01 for both). AIx@75 was elevated in both groups 
28 
at 10 min post-exercise (p<0.03 for both), but returned to baseline values at 30 min post 
(see Table 4). As shown in Figure 5, pPWV was decreased at 10 min post-exercise for both 
ECCarm and CONarm (p<0.05), while both groups returned to baseline values by 30 min 
post. cPWV did not change in either group.  
 
Figure 6: Peripheral (i.e. arm) pulse wave velocity (pPWV) was significantly decreased at 
10 min post-exercise in both groups, but returned to baseline at 30 min post (Panel A). 
Central (i.e. aortic) pulse wave velocity (cPWV) was not changed from baseline at 10 or 
30 min post-exercise for either group (Panel B). * p<0.05 vs. pre-exercise baseline.
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Table 4: Cardiovascular responses to acute exercise session. 
 Eccentric (n=11)  Concentric (n=11) 
Variable Pre-Exercise 
10 min 
Post-
Exercise 
30 min 
Post-
Exercise 
 Pre- Exercise 
10 min 
Post-
Exercise 
30 min 
Post-
Exercise 
HR (bpm) 64 ± 3 68 ± 3 61 ± 2  60 ± 3 71 ± 4* 66 ± 3 
bMAP 
(mmHg)  76 ± 3 79 ± 2 75 ± 2 
 77 ± 2 72 ± 2 74 ± 2 
AIx@75 -9 ± 3 0 ± 3* -4 ± 3  -14 ± 4 -4 ± 3* -12 ± 3 
aSAP (mmHg) 91 ± 3 96 ± 2 93 ± 2  92 ± 2 89 ± 2 87 ± 3 
aDAP (mmHg) 61 ± 3 59 ± 2 59 ± 2  63 ± 2 52 ± 2 54 ± 2 
aMAP 
(mmHg) 74 ± 3 76 ± 2 74 ± 2 
 74 ± 2 69 ± 2 69 ± 2 
aPP (mmHg) 31 ± 1 38 ± 1* 35 ± 1  31 ± 2 37 ± 2* 35 ± 2 
aPL (aU) 1907 ± 136 2607 ± 184* 2074 ± 130*  1800 ± 107 2440 ± 121* 2179 ± 172* 
Values are reported as Mean ± SE. Heart rate (HR), brachial mean atrial pressure (bMAP), aortic augmentation 
index normalized to 75 beats per minute (Aix@75), aortic systolic blood pressure (aSAP), aortic diastolic blood 
pressure (aDAP), aortic mean blood pressure (aMAP), aortic pulse pressure (aPP), aortic pulsatile load (aPL). * 
p<0.05 vs. pre-exercise baseline 
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3.4 Discussion 
This study compared arterial stiffness responses to acute steady-state eccentric and 
concentric upper body cycling. The main finding of our study was that both eccentric and 
concentric upper body cycling elicit similar acute arterial stiffness responses. This is 
supported by three novel findings. First, pPWV measured in the arm was reduced at 10 
min post-exercise after both eccentric and concentric arm ergometry, but returned to pre-
exercise values by 30 min post-exercise. Second, cPWV was similar to pre-exercise 
baseline values at 10 and 30 min post-eccentric and post-concentric arm ergometry. Third, 
AIx@75 was elevated at 10 min post-exercise, but returned to baseline values at 30 min 
post-exercise in both groups.  
 Our pPWV results (top panel of Figure 5) are in agreement with findings from 
Ranadive et al. (2012), who reported that maximal concentric upper body cycling can 
acutely decrease arterial stiffness in the arm. Acute decreases in pPWV are thought to be 
largely due to increases in nitric oxide which can contribute to vasodilation (C. Goto et al., 
2003). Additionally, our observation that cPWV did not change through concentric arm 
cycling agrees with previous findings from Ranadive et al. (2012). However, it was not 
previously known if eccentric arm cycling would elicit similar responses.  
Arm cycling recruits a smaller muscle mass compared to many other forms of aerobic 
exercise, such as running or biking. Therefore, arm blood flow is higher during arm cycling 
compared to whole body exercise (Volianitis & Secher, 2002). Hence, it is plausible that 
the vasculature in the arms would be primarily effected during our protocol and not the 
descending aorta. Furthermore, changes in the stiffness of muscular peripheral arteries are 
 31 
due to changes in endothelial function, whereas the central arteries change more so due to 
structural changes associated with aging (Choi et al., 2010).  
AIx has been demonstrated to be influenced independently from pulse wave velocity 
and is affected by heart rate to a greater extent (Kelly et al., 2001). Heart rate returned to 
baseline values by 30 min post-eccentric arm cycling, but was still elevated at 30 min post-
concentric arm cycling. This may partially explain the disparity between AIx and PWV 
responses. Increases in aortic pulse pressure were similar at 30 min post-exercise for the 
eccentric and concentric groups (~4 mmHg). Elevated aortic pulse pressure, and / or heart 
rate, can increase the pulsatility to end organs such as the brain and kidney and lead to 
long-term damage (Augustine et al., 2016). Increased aortic pulsatility is also noted to 
increase the risk for coronary heart disease (Nishijima et al., 2001). Aortic pulsatile load 
increased after exercise and remained elevated 30 minutes after in each group.  
It would be beneficial to include more female participants in future studies to allow 
for potential sex differences to be examined. Measurements of PWV were taken at 10 and 
30 minutes to measure acute changes following exercise and after a brief recovery. 
However, it would be beneficial to add additional time points, as the cardiovascular system 
can rapidly change following exercise.  
Our findings have potential implications for clinicians who prescribe exercise to 
improve upper body strength to patient populations, especially those with cardiovascular 
impairments. Specifically, our results demonstrate that eccentric arm cycling can be used 
to provide significant mechanical stress at moderate levels of perceived exertion while not 
increasing arterial stiffness. This exercise modality could also be useful in athletic 
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populations to increase performance in which upper-body strength and endurance is 
important, such as rowing or cross-country skiing. 
These acute findings, in conjunction with our recent longitudinal training study that 
indicated no change in pPWV or cPWV (Elmer et al., 2017), demonstrate that eccentric 
arm cycling does not appear to negatively influence arterial stiffness. These results are 
promising, considering that participants increased their upper body strength and power in 
our longitudinal eccentric exercise study (Elmer et al., 2017), whereas traditional 
longitudinal upper body resistance training has been reported to increase pulse wave 
velocity (Okamoto et al., 2009). These findings indicate that eccentric arm cycling appears 
to be safe for healthy individuals in regard to arterial function. It is currently unknown if 
these findings will extend to those with pre-clinical, or clinical, conditions such as 
hypertension or coronary artery disease. 
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4 Summary, Limitations, and Future Directions 
4.1 Summary 
Our results suggest that a key to reducing the negative effects of resistance exercise 
on arterial function is to combine it with aerobic exercise, either within a single session or 
simultaneously. Eccentric arm cycling is a novel form of resistance exercise at aerobic 
capacities that prevents adverse arterial responses.    
4.2 Limitations 
Both studies have a pool of young, healthy individuals. Although this is an important 
first step to determine the effects of combined resistance and aerobic exercise, it limits our 
ability to prescribe exercise to clinical populations. Additionally, our sample is not large 
enough to adequately examine potential sex differences – something that continues to be 
absent in much of the literature.  
Peripheral stiffness measurements were focused only in the arm (carotid-radial). 
Recently, there has been a focus on differential response in the upper and lower arterial 
segments (Mutter, Cooke, Saleh, Gomez, & Daskalopoulou, 2017). Additional recordings 
of femoral-pedal pulse wave velocities could further our understanding of cardiovascular 
responses to combined resistance and aerobic exercise.  
4.3 Future Directions 
Future studies could use more invasive measures to determine the mechanisms that 
are responsible for the observed cardiovascular responses. This might include 
measurements of nitric oxide, endothelin-1, and other vasoactive substances. Another 
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regulatory mechanism that could be further studied is muscle sympathetic nerve activity, 
which is associated with arterial stiffness (Swierblewska et al., 2010). Ultrasonography and 
the flow-mediated dilation technique could also offer further insight into the changes in 
arterial diameter and stiffness after eccentric exercise.  
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Appendix A. Raw Data for Study 1 
A.1 Demographic Information 
SUBECT 
# SEX 
AGE 
(year) 
HEIGHT  
(cm) 
WEIGHT 
(kg) 
BMI 
(kg/m2) 
SAP 
(mmHg) 
DAP 
(mmHg) 
MAP 
(mmHg) 
HR 
(bpm) 
1 M 33 181 95.6 29.2 137 79 98 59 
2 F 22 170 61.8 21.4 93 58 70 45 
3 F 20 168 59.8 21.2 107 57 74 56 
4 M 41 173 96.0 32.1 115 62 80 56 
5 M 21 180 84.0 25.9 128 70 89 66 
6 M 19 184 81.4 24.0 125 44 71 52 
7 M 21 176 72.2 23.3 120 73 89 61 
8 F 32 165 56.9 20.9 118 77 91 50 
9 M 29 186 101.4 29.3 142 83 103 72 
10 M. 21 173 80.2 26.8 125 76 92 66 
11 M 21 166 85.5 31.0 117 61 80 67 
12 M 21 179 80.8 25.2 110 53 72 61 
13 M 19 170 73.3 25.4 123 67 86 77 
14 M 19 166 61.9 22.5 115 66 82 56 
15 M 19 178 81.5 25.7 101 50 67 50 
16 F 19 178 81.0 25.6 114 61 79 57 
17 F 36 173 70.9 23.7 108 71 83 50 
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A.2 Target Heart Rate and 10 RM Strength Test 
Subject 
# 
Target 
HR 
(bpm) 
Barbell 
Squat 
(lbs) 
Barbell 
Bench 
Press 
(lbs) 
Seated 
Lat Pull 
Down 
(lbs) 
Triceps 
Pushdown 
(lbs) 
Biceps  
Curl 
(lbs) 
Single 
Leg 
Lunge 
(lbs) 
1 149 185 165 130 60 55 65 
2 152 115 95 60 40 40 65 
3 157 115 55 60 30 30 65 
4 142 80 155 90 60 55 30 
5 159 155 115 70 40 50 25 
6 156 225 105 100 50 50 95 
7 158 135 145 110 50 55 55 
8 146 85 75 60 30 30 15 
9 155 135 115 100 50 45 45 
10 159 95 155 100 60 70 25 
11 159 175 125 70 50 65 75 
12 158 205 155 90 40 45 110 
13 164 155 125 70 40 50 25 
14 157 205 125 60 40 35 105 
15 156 155 105 90 40 45 0 
16 158 155 75 80 40 45 50 
17 143 65 60 50 30 30 25 
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A.3 Brachial Hemodynamics: RA Pre-Exercise 
Subject # SAP DAP MAP HR 
1 144 65 91 96 
2 112 54 73 62 
3 145 63 90 99 
4 145 78 100 77 
5 135 60 85 97 
6 135 47 76 57 
7 140 66 91 106 
8 123 67 86 67 
9 182 63 103 117 
10 115 53 74 101 
11 149 49 82 51 
12 148 47 81 111 
13 133 75 94 109 
14 137 59 85 121 
15 109 40 63 99 
16 120.0 57 78 64 
17 120.0 68 85 80 
A.4 Brachial Hemodynamics: AR Pre-Exercise 
Subject # SAP DAP MAP HR 
1 119 68 85 53 
2 103 58 73 45 
3 104 52 69 52 
4 115 62 80 56 
5 127 67 87 66 
6 113 52 72 54 
7 119 70 86 70 
8 118 77 91 50 
9 141 72 95 71 
10 120 68 85 78 
11 111 56 74 48 
12 115 64 81 52 
13 120 64 83 72 
14 121 68 86 51 
15 103 52 69 54 
16 116 59 78 55 
17 110 66 81 48 
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A.5 Brachial Hemodynamics: RA Mid-Exercise 
Subject # SAP DAP MAP HR 
1 144 65 91 96 
2 112 54 73 62 
3 145 63 90 99 
4 145 78 100 77 
5 135 60 85 97 
6 135 47 76 57 
7 140 66 91 106 
8 123 67 86 67 
9 182 63 103 117 
10 115 53 74 101 
11 149 49 82 51 
12 148 47 81 111 
13 133 75 94 109 
14 137 59 85 121 
15 109 40 63 99 
16 120 57 78 64 
17 120 68 85 80 
A.6 Brachial Hemodynamics: AR Mid-Exercise 
Subject # SAP DAP MAP HR 
1 137 66 90 122 
2 137 67 90 86 
3 127 66 86 99 
4 137 58 84 106 
5 140 62 88 119 
6 134 56 82 69 
7 114 70 85 112 
8 120 72 88 65 
9 151 53 86 105 
10 125 62 83 107 
11 133 50 78 97 
12 125 38 67 106 
13 136 61 86 108 
14 143 64 90 118 
15 137 52 80 100 
16 123 67 86 83 
17 141 72 95 100 
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A.7 Brachial Hemodynamics: RA 0 Minutes Post-Exercise 
Subject # SAP DAP MAP HR 
1 147 73 98 94 
2 121 67 85 76 
3 122 73 89 98 
4 121 87 98 88 
5 133 71 92 102 
6 138 60 86 80 
7 143 79 100 114 
8 143 73 96 87 
9 160 79 106 106 
10 111 57 75 102 
11 132 55 81 103 
12 125 67 86 85 
13 132 56 81 109 
14 132 51 78 114 
15 143 58 86 103 
16 129 72 91 99 
17 121 73 89 89 
A.8 Brachial Hemodynamics: AR 0 Minutes Post-Exercise 
Subject # SAP DAP MAP HR 
1 137 66 90 122 
2 137 67 90 86 
3 127 66 86 99 
4 137 58 84 106 
5 140 62 88 119 
6 134 56 82 69 
7 114 70 85 112 
8 120 72 88 65 
9 151 53 86 105 
10 125 62 83 107 
11 133 50 78 97 
12 125 38 67 106 
13 136 61 86 108 
14 143 64 90 118 
15 137 52 80 100 
16 123 67 86 83 
17 141 72 95 100 
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A.9 Brachial Hemodynamics: RA 30 Minutes Post-Exercise 
Subject # SAP DAP MAP HR 
1 122 69 87 60 
2 106 72 83 59 
3 104 60 75 70 
4 120 72 88 77 
5 121 68 86 75 
6 112 50 71 55 
7 110 67 81 85 
8 113 71 85 66 
9 126 74 91 82 
10 106 48 67 95 
11 116 53 74 82 
12 110 54 73 66 
13 124 81 95 87 
14 111 48 69 84 
15 97 49 65 85 
16 110 59 76 67 
17 109 71 84 55 
A.10 Brachial Hemodynamics: AR 30 Minutes Post-Exercise 
Subject # SAP DAP MAP HR 
1 117 57 77 79 
2 107 61 76 57 
3 107 55 72 69 
4 120 69 86 81 
5 115 56 76 95 
6 120 52 75 53 
7 101 56 71 90 
8 116 73 87 58 
9 114 54 74 75 
10 122 64 83 89 
11 102 44 63 79 
12 110 44 66 87 
13 110 53 72 98 
14 120 35 63 117 
15 99 39 59 78 
16 115 58 77 69 
17 110 68 82 64 
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A.11 Pulse Wave Analysis Trial 1: RA Pre-Exercise 
Subject # aSAP aDAP aMAP aPP 
1 104 77 89 27 
2 87 60 72 27 
3 90 57 73 33 
4 100 69 82 31 
5 104 76 89 28 
6 86 51 64 35 
7 90 62 75 28 
8 102 73 86 29 
9 123 84 102 39 
10 86 61 73 25 
11 92 57 74 35 
12 91 58 71 33 
13 102 70 84 32 
14 95 68 80 27 
15 79 50 62 29 
16 83 57 67 26 
17 99 71 82 28 
A.12 Pulse Wave Analysis Trial 2: RA Pre-Exercise 
Subject # aSAP aDAP aMAP aPP 
1 104 77 88 27 
2 87 61 73 26 
3 89 57 72 32 
4 100 69 83 31 
5 104 76 90 28 
6 86 51 63 35 
7 90 62 74 28 
8 104 73 87 31 
9 124 84 102 40 
10 85 61 72 24 
11 92 57 73 35 
12 94 59 72 35 
13 101 70 84 31 
14 92 67 79 25 
15 78 50 61 28 
16 83 57 68 26 
17 98 71 81 27 
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A.13 Pulse Wave Analysis Trial 1: AR Pre-Exercise 
Subject # aSAP aDAP aMAP aPP 
1 99 69 81 30 
2 84 58 68 26 
3 87 53 70 34 
4 95 62 76 33 
5 101 67 79 34 
6 88 52 66 36 
7 98 71 83 27 
8 111 77 93 34 
9 113 73 91 40 
10 101 69 85 32 
11 91 57 71 34 
12 97 64 78 33 
13 96 65 78 31 
14 104 69 85 35 
15 82 52 65 30 
16 97 60 77 37 
17 96 66 78 30 
A.14 Pulse Wave Analysis Trial 2: AR Pre-Exercise 
Subject # aSAP aDAP aMAP aPP 
1 100 68 80 32 
2 84 58 70 26 
3 86 53 69 33 
4 96 63 77 33 
5 101 67 79 34 
6 88 52 66 36 
7 98 71 85 27 
8 111 77 92 34 
9 112 73 91 39 
10 98 69 82 29 
11 91 57 71 35 
12 97 65 78 32 
13 96 64 78 32 
14 104 69 85 35 
15 83 52 64 31 
16 96 60 75 36 
17 97 66 79 31 
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A.15 Pulse Wave Analysis Trial 1: RA Mid-Exercise 
Subject # aSAP aDAP aMAP aPP 
1 . . . . 
2 93 55 72 38 
3 109 64 79 45 
4 120 80 97 40 
5 105 64 81 41 
6 99 47 65 52 
7 112 69 87 43 
8 105 68 85 37 
9 131 66 89 65 
10 94 54 73 40 
11 114 55 80 59 
12 105 50 69 55 
13 105 59 79 46 
14 106 63 83 43 
15 89 41 62 48 
16 84 58 70 26 
17 99 69 84 30 
A.16 Pulse Wave Analysis Trial 2: RA Mid-Exercise 
Subject # aSAP aDAP aMAP aPP 
1 . . . . 
2 93 55 73 38 
3 . . . . 
4 120 80 98 40 
5 105 64 81 41 
6 100 48 68 52 
7 112 69 87 43 
8 104 68 85 36 
9 131 67 91 64 
10 92 54 71 38 
11 114 54 79 60 
12 107 48 73 59 
13 104 59 79 45 
14 106 62 83 44 
15 88 42 62 46 
16 83 57 69 26 
17 100 69 85 31 
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A.17 Pulse Wave Analysis Trial 1: AR Mid-Exercise 
Subject # aSAP aDAP aMAP aPP 
1 113 76 90 37 
2 93 59 68 34 
3 106 75 90 31 
4 119 77 97 42 
5 119 78 95 41 
6 110 60 81 50 
7 106 79 91 27 
8 112 82 97 30 
9 118 76 94 42 
10 93 65 78 28 
11 102 57 80 45 
12 111 74 89 37 
13 106 65 83 41 
14 102 72 87 30 
15 104 69 84 35 
16 103 71 86 32 
17 106 80 93 26 
A.18 Pulse Wave Analysis Trial 2: AR Mid-Exercise 
Subject # aSAP aDAP aMAP aPP 
1 113 76 88 37 
2 92 58 68 34 
3 105 75 89 33 
4 119 77 97 42 
5 119 77 95 42 
6 109 60 81 49 
7 106 79 91 27 
8 112 82 97 30 
9 119 76 94 43 
10 94 65 77 29 
11 101 57 77 44 
12 110 74 89 36 
13 107 68 84 39 
14 102 72 87 30 
15 109 70 87 39 
16 103 71 86 32 
17 106 80 93 26 
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A.19 Pulse Wave Analysis Trial 1: RA 0 Minutes Post-Exercise 
Subject # aSAP aDAP aMAP aPP 
1 118 78 96 40 
2 100 68 84 32 
3 102 76 89 26 
4 108 89 98 19 
5 108 75 89 33 
6 108 62 83 46 
7 118 83 100 35 
8 119 76 98 43 
9 127 85 102 42 
10 92 59 73 33 
11 101 59 76 42 
12 105 71 84 34 
13 110 80 94 30 
14 99 55 76 44 
15 112 61 84 51 
16 105 75 89 30 
17 103 75 90 28 
A.20 Pulse Wave Analysis Trial 2: RA 0 Minutes Post-Exercise 
Subject # aSAP aDAP aMAP aPP 
1 120 76 94 44 
2 104 69 87 35 
3 102 76 88 26 
4 108 89 98 19 
5 108 75 90 33 
6 109 62 83 47 
7 118 83 98 35 
8 120 75 98 45 
9 126 83 100 43 
10 92 59 74 33 
11 101 59 76 42 
12 104 72 84 32 
13 110 80 94 30 
14 99 55 76 44 
15 107 59 80 48 
16 106 74 90 32 
17 104 75 90 29 
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A.21 Pulse Wave Analysis Trial 1: AR 0 Minutes Post-Exercise 
Subject # aSAP aDAP aMAP aPP 
1 109 73 85 36 
2 107 68 86 39 
3 106 68 85 38 
4 110 70 84 40 
5 108 65 83 43 
6 103 57 75 46 
7 97 72 82 25 
8 107 73 90 34 
9 112 60 79 52 
10 103 62 80 41 
11 101 56 76 45 
12 89 41 60 48 
13 103 51 75 52 
14 110 68 89 42 
15 111 56 77 55 
16 100 68 83 32 
17 115 75 93 40 
A.22 Pulse Wave Analysis Trial 2: AR 0 Minutes Post-Exercise 
Subject # aSAP aDAP aMAP aPP 
1 109 72 85 37 
2 107 68 83 39 
3 104 68 84 36 
4 108 67 82 41 
5 108 64 82 44 
6 104 57 76 47 
7 97 72 82 25 
8 105 73 88 32 
9 114 58 79 56 
10 104 64 81 40 
11 103 58 76 45 
12 91 40 61 51 
13 102 51 74 51 
14 110 68 89 42 
15 112 54 77 58 
16 102 69 85 33 
17 114 74 94 40 
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A.23 Pulse Wave Analysis Trial 1: RA 30 Minutes Post-Exercise 
Subject # aSAP aDAP aMAP aPP 
1 100 70 83 30 
2 93 72 81 21 
3 . . . . 
4 102 74 86 28 
5 99 69 81 30 
6 86 50 65 36 
7 94 69 80 25 
8 98 72 85 26 
9 103 75 87 28 
10 87 53 66 34 
11 91 55 72 36 
12 87 55 69 32 
13 105 82 92 23 
14 87 49 65 38 
15 82 55 64 27 
16 92 60 74 32 
17 96 72 83 24 
A.24 Pulse Wave Analysis Trial 2: RA 30 Minutes Post-Exercise 
Subject # aSAP aDAP aMAP aPP 
1 100 70 83 30 
2 93 73 82 20 
3 . . . . 
4 102 73 86 29 
5 99 69 82 30 
6 86 50 61 36 
7 92 68 77 24 
8 100 72 86 28 
9 103 75 87 28 
10 86 52 65 34 
11 90 55 71 35 
12 88 55 70 33 
13 105 83 93 22 
14 86 50 67 36 
15 81 54 63 27 
16 91 60 74 31 
17 97 72 83 25 
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A.25 Pulse Wave Analysis Trial 1: AR 30 Minutes Post-Exercise 
Subject # aSAP aDAP aMAP aPP 
1 92 61 73 31 
2 87 61 73 26 
3 85 56 67 29 
4 101 71 84 30 
5 92 61 73 31 
6 91 53 67 38 
7 85 60 69 25 
8 102 74 87 28 
9 89 54 66 35 
10 99 66 79 33 
11 79 46 61 33 
12 88 52 66 36 
13 89 60 70 29 
14 85 41 59 44 
15 77 44 55 33 
16 91 59 74 32 
17 95 69 82 26 
A.26 Pulse Wave Analysis Trial 2: AR 30 Minutes Post-Exercise 
Subject # aSAP aDAP aMAP aPP 
1 91 59 71 32 
2 87 62 73 25 
3 86 56 72 30 
4 101 71 84 30 
5 93 64 75 29 
6 91 52 65 39 
7 85 62 70 23 
8 102 74 88 28 
9 90 55 68 35 
10 99 67 80 32 
11 78 45 59 33 
12 88 52 66 36 
13 88 59 71 29 
14 87 41 60 46 
15 74 41 53 33 
16 91 58 73 33 
17 94 69 81 25 
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A.27 Pulse Wave Velocity: RA Pre-Exercise 
 Peripheral PWV (m/s) Central PWV (m/s) 
 Trial 1 Trial 2 Trial 1 Trial 2 
Subject # Value SD Value SD Value SD Value SD 
1 8.6 0.2 9.9 0.5 8.5 0.4 6.5 0.3 
2 4.1 0.2 6.9 0.3 5.3 0.2 6.2 0.4 
3 7.7 0.7 6.2 0.5 5.0 0.3 . . 
4 8.2 0.6 7.2 0.5 6.1 0.3 6.5 0.6 
5 7.2 4.4 7.9 0.4 5.8 0.3 5.4 0.3 
6 5.6 0.3 6.3 0.5 4.7 0.4 5.3 0.3 
7 8.2 0.8 6.9 0.4 8.5 0.8 7.8 0.5 
8 8.5 0.8 8.0 0.6 5.8 0.4 5.3 0.4 
9 7.8 0.4 7.9 0.5 7.1 0.6 7.2 0.6 
10 7.1 0.6 6.2 0.4 5.3 0.5 4.8 0.3 
11 6.6 0.6 7.1 0.6 5.4 0.5 6.4 0.3 
12 7.7 0.7 7.1 0.6 4.1 0.2 5.0 0.4 
13 6.1 0.4 6.8 0.5 5.0 0.2 5.6 0.3 
14 7.6 0.8 11.3 1.2 4.8 0.3 5.8 0.4 
15 6.3 0.4 7.0 0.5 4.3 0.2 4.8 0.2 
16 5.5 0.6 5.1 0.3 4.8 0.4 4.7 0.3 
17 8.9 0.5 8.2 0.7 6.5 0.2 6.0 0.3 
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A.28 Pulse Wave Velocity: AR Pre-Exercise 
 Peripheral PWV (m/s) Central PWV (m/s) 
 Trial 1 Trial 2 Trial 1 Trial 2 
Subject # Value SD Value SD Value SD Value SD 
1 6.6 0.6 9.6 0.6 5.9 0.3 6.0 0.4 
2 7.3 0.7 9.1 0.4 4.8 0.3 5.6 0.5 
3 6.0 0.4 7.2 0.4 5.0 0.4 4.4 0.2 
4 8.9 0.7 7.4 0.5 7.6 0.6 6.0 0.3 
5 7.6 0.5 7.0 0.5 6.2 0.3 6.5 0.5 
6 6.5 0.4 6.8 0.3 4.7 0.2 6.0 0.4 
7 7.3 0.7 7.3 0.4 5.7 0.4 5.7 0.5 
8 8.4 0.8 8.5 0.7 7.3 0.7 6.5 0.5 
9 7.1 0.5 7.4 0.5 6.4 0.6 6.9 0.5 
10 5.3 0.2 4.8 0.2 5.4 0.3 5.6 0.3 
11 6.5 0.4 6.2 0.6 6.0 0.5 5.7 0.5 
12 6.1 0.3 7.0 0.5 4.4 0.2 5.2 0.5 
13 6.9 0.5 7.1 0.4 5.9 0.5 5.2 0.5 
14 8.9 0.8 8.0 0.5 5.3 0.4 5.5 0.3 
15 6.1 0.5 7.0 0.6 3.8 0.2 3.9 0.2 
16 5.8 0.5 5.9 0.5 4.6 0.3 5.3 0.5 
17 11.3 0.9 9.2 0.6 5.5 0.3 5.4 0.2 
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A.29 Pulse Wave Velocity: RA Mid-Exercise 
 Peripheral PWV (m/s) Central PWV (m/s) 
 Trial 1 Trial 2 Trial 1 Trial 2 
Subject # Value SD Value SD Value SD Value SD 
1 10.6 0.6 7.9 0.4 7.4 0.4 7.2 10.6 
2 7.2 0.6 7.5 0.4 6.9 0.4 6.3 7.2 
3 5.7 0.2 6.3 0.3 5.0 0.2 5.1 5.7 
4 7.5 0.4 7.4 0.5 7.1 0.4 7.3 7.5 
5 6.9 0.2 6.4 0.2 6.9 0.5 6.6 6.9 
6 6.2 0.4 7.0 0.3 5.1 0.3 5.4 6.2 
7 5.3 0.3 5.7 0.5 7.0 0.4 6.8 5.3 
8 9.3 0.8 7.0 0.3 5.6 0.3 6.0 9.3 
9 7.6 0.4 7.5 0.3 6.1 0.3 8.2 7.6 
10 5.4 0.2 4.9 0.2 5.1 0.2 5.2 5.4 
11 6.4 0.3 5.8 0.3 7.6 0.4 5.9 6.4 
12 6.3 0.3 6.4 0.3 4.8 0.2 4.4 6.3 
13 7.6 0.4 6.7 0.4 5.2 0.2 6.0 7.6 
14 6.3 0.3 6.7 0.3 5.8 0.4 5.4 6.3 
15 4.5 0.2 5.1 0.3 4.6 0.3 4.0 4.5 
16 5.5 0.2 5.8 0.3 5.6 0.6 5.6 5.5 
17 8.3 0.3 7.9 0.3 5.9 0.3 5.8 8.3 
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A.30 Pulse Wave Velocity: AR Mid-Exercise 
 Peripheral PWV (m/s) Central PWV (m/s) 
 Trial 1 Trial 2 Trial 1 Trial 2 
Subject # Value SD Value SD Value SD Value SD 
1 10.6 1.0 9.5 0.5 7.3 0.5 6.2 0.3 
2 6.8 0.4 6.7 0.4 4.4 0.3 4.5 0.3 
3 8.0 0.5 5.8 0.3 5.2 0.2 4.8 0.3 
4 8.7 0.6 8.5 0.6 7.7 0.4 8.7 0.4 
5 5.3 0.1 6.1 0.2 6.0 0.2 6.6 0.3 
6 6.4 0.5 6.3 0.3 4.5 0.2 6.0 0.5 
7 8.1 0.4 6.5 0.3 6.2 0.3 6.0 0.4 
8 7.8 0.5 8.9 0.7 6.1 0.5 6.9 0.6 
9 9 0.7 7.7 0.5 6.0 0.4 7.8 0.7 
10 7.2 0.2 6.2 0.2 5.5 0.1 5.9 0.2 
11 6.0 0.3 6.3 0.2 5.9 0.3 6.6 0.4 
12 8.0 0.4 7.4 0.4 5.1 0.2 . . 
13 6.1 0.3 6.1 0.3 4.8 0.2 5.3 0.3 
14 9.1 0.6 7.5 0.7 4.8 0.3 6.0 0.4 
15 7.1 0.4 6.0 0.5 4.3 0.2 4.1 0.2 
16 7.7 0.5 7.1 0.6 5.3 0.5 5.8 0.6 
17 10.4 0.9 8.0 0.5 5.5 0.1 5.9 0.2 
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A.31 Pulse Wave Velocity: RA 0 Min Post-Exercise 
 Peripheral PWV (m/s) Central PWV (m/s) 
 Trial 1 Trial 2 Trial 1 Trial 2 
Subject # Value SD Value SD Value SD Value SD 
1 9.9 0.7 10.5 0.6 7.7 0.5 6.6 0.4 
2 6.9 0.3 7.8 0.3 6.1 0.5 6.6 0.3 
3 6.7 0.5 6.6 0.2 4.3 0.2 4.6 0.2 
4 7.8 0.3 8.5 0.3 6.9 0.4 7.3 0.4 
5 6.8 0.3 8.0 0.5 5.9 0.3 5.1 0.3 
6 6.4 0.4 6.0 0.3 5.8 0.4 5.7 0.4 
7 6.1 0.2 7.4 0.4 5.5 0.3 5.1 0.4 
8 9.1 0.6 7.8 0.4 4.7 0.2 5.7 0.4 
9 9.5 0.5 8.1 0.7 7.7 0.6 8.2 0.7 
10 6.0 0.2 6.8 0.2 4.7 0.2 4.8 0.2 
11 6.4 0.2 7.1 0.2 7.0 0.3 8.8 0.5 
12 6.9 0.4 7.0 0.3 5.3 0.3 4.6 0.3 
13 7.2 0.5 6.4 0.3 5.9 0.3 5.0 0.2 
14 7.1 0.4 6.7 0.4 5.1 0.3 5.4 0.2 
15 5.0 0.2 5.3 0.3 3.8 0.1 4.0 0.2 
16 6.7 0.4 5.8 0.4 5.0 0.4 5.3 0.5 
17 9.9 0.8 8.9 0.6 5.4 0.2 5.6 0.3 
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A.32 Pulse Wave Velocity: AR 0 Min Post-Exercise 
 Peripheral PWV (m/s) Central PWV (m/s) 
 Trial 1 Trial 2 Trial 1 Trial 2 
Subject # Value SD Value SD Value SD Value SD 
1 7.8 0.4 7.8 0.3 7.6 0.5 7.7 0.5 
2 6.7 0.4 6.0 0.2 4.9 0.3 5.1 0.2 
3 6.5 0.3 6.0 0.4 5.7 0.3 5.8 0.2 
4 7.5 0.4 7.9 0.5 6.8 0.4 8.7 0.5 
5 6.5 0.3 5.3 0.2 7.3 0.5 6.0 0.2 
6 7.0 0.7 6.3 0.4 5.1 0.2 4.6 0.2 
7 5.8 0.2 6.3 0.3 5.5 0.4 5.4 0.3 
8 7.7 0.4 8.4 0.3 6.9 0.5 7.5 0.4 
9 7.0 0.3 6.1 0.2 6.4 0.4 6.9 0.5 
10 5.3 0.2 5.1 0.3 5.8 0.4 6.2 0.3 
11 6.1 0.3 5.5 0.1 6.7 0.5 6.9 0.3 
12 5.7 0.2 5.3 0.3 4.7 0.3 4.4 0.2 
13 7.0 0.3 6.7 0.4 4.8 0.2 5.1 0.2 
14 6.3 0.4 7.1 0.4 5.0 0.3 5.9 0.3 
15 5.1 0.2 5.3 0.3 4.2 0.2 4.0 0.2 
16 7.9 0.6 7.5 0.8 5.6 0.4 5.7 0.5 
17 7.5 0.4 8.1 0.4 5.9 0.3 6.6 0.4 
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A.33 Pulse Wave Velocity: RA 30 Min Post-Exercise 
 Peripheral PWV (m/s) Central PWV (m/s) 
 Trial 1 Trial 2 Trial 1 Trial 2 
Subject # Value SD Value SD Value SD Value SD 
1 8.8 0.3 9.1 0.4 6.3 0.3 7.5 0.6 
2 7.4 0.5 . . 6.3 0.5 7.0 0.6 
3 6.6 0.4 7.7 0.4 4.4 0.1 4.4 0.3 
4 7.3 0.8 8.3 0.5 5.8 0.4 6.1 0.4 
5 6.6 0.2 5.9 0.3 5.2 0.2 6.6 0.3 
6 6.5 0.5 5.7 0.4 4.9 0.3 4.3 0.2 
7 8.2 0.6 8.4 0.5 6.4 0.5 5.6 0.5 
8 9.8 1.0 9.2 0.7 5.8 0.4 5.5 0.2 
9 7.6 0.5 7.4 0.3 6.6 0.3 6.1 0.3 
10 5.7 0.2 5.7 0.2 5.0 0.3 4.6 0.2 
11 5.7 0.3 6.1 0.5 6.2 0.6 5.4 0.4 
12 7.3 0.3 6.4 0.2 4.4 0.2 4.6 0.3 
13 6.6 0.3 7.2 0.6 4.9 0.3 6.2 0.3 
14 5.4 0.2 6.6 0.4 4.7 0.3 4.4 0.4 
15 4.6 0.2 5.5 0.5 4.2 0.2 4.5 0.3 
16 5.8 0.4 5.6 0.3 4.3 0.3 4.9 0.3 
17 8.0 0.5 7.7 0.5 6.7 0.4 5.7 0.4 
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A.34 Pulse Wave Velocity: AR 30 Min Post-Exercise 
 Peripheral PWV (m/s) Central PWV (m/s) 
 Trial 1 Trial 2 Trial 1 Trial 2 
Subject # Value SD Value SD Value SD Value SD 
1 10.5 0.9 10.1 0.7 6.3 0.4 5.9 0.3 
2 . . . . 4.5 0.3 6.0 0.3 
3 6.1 0.2 6.1 0.4 3.9 0.1 4.2 0.2 
4 7.8 0.4 7.7 0.4 5.6 0.2 6.3 0.3 
5 4.8 0.2 6.6 0.3 5.4 0.2 5.2 0.2 
6 6.7 0.2 6.4 0.4 5.7 0.5 5.3 0.4 
7 6.7 0.5 6.6 0.4 5.5 0.3 6.3 0.4 
8 7.0 0.4 6.2 0.5 6.2 0.5 7.1 0.4 
9 7.1 0.5 7.1 0.4 7.5 0.5 6.9 0.4 
10 6.2 0.3 5.2 0.2 4.8 0.2 5.8 0.3 
11 6.4 0.3 6.2 0.2 5.1 0.2 4.9 0.4 
12 6.9 0.4 5.6 0.1 5.0 0.2 5.1 0.2 
13 6.5 0.3 6.6 0.3 4.9 0.2 5.4 0.2 
14 7.1 0.5 6.2 0.3 6.0 0.4 5.0 0.2 
15 4.8 0.2 5.1 0.4 3.6 0.2 3.4 0.1 
16 7.2 0.6 8.2 0.9 6.0 0.4 5.5 0.4 
17 8.0 0.4 9.2 4.0 6.0 0.3 5.5 0.3 
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Appendix B. Summary Statistics for Study 1 
B.1 Aortic Pulsatile Load 
Repeated Measures ANOVA 
 
Within Subjects 
Effect 
Mauchy’s 
W 
Approx. Chi-
Squate df Sig. 
Greenhouse-
Geisser 
Condition 1.000 0.000 0 . 1.000 
Time 0.607 6.346 5 0.275 0.760 
Condition * Time 0.151 24.086 5 0.000 0.617 
 
Source  
Type III Sum 
of Squares df Mean Square F 
 
Sig 
Time Sphericity Assumed 77125740.90 3 25708580.30 54.080 0.000 
 Greenhouse-Geisser 77125740.90 2.279 33847235.59 54.080 0.000 
Time x 
Condition 
Sphericity 
Assumed 9093383.067 3 3031127.689 6.914 0.001 
 Greenhouse-Geisser 9093383.067 1.850 4916622.719 6.914 0.005 
 
Paired T-Tests 
 
 95% Confidence Interval    
 Mean Lower Upper T df 
Sig.  
(2-tailed) 
Pre-RA – Mid-RA -2229.188 -2883.141 -1575.234 -7.266 15 0.000 
Pre-RA – P10-RA -1605.941 -2065.932 -1145.950 -7.401 16 0.000 
Pre-RA – P30-RA -426.375 -714.553 -138.197 -3.154 15 0.007 
Pre-AR – Mid-AR -1286.118 -1581.767 -990.468 -9.222 16 0.000 
Pre-AR – P10-AR -2086.824 -2599.207 -1574.440 -8.634 16 0.000 
Pre-AR – P30-AR -632.765 -963.091 -302.439 -4.061 16 0.001 
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B.2 Peripheral Pulse Wave Velocity 
Repeated Measures ANOVA 
 
Within Subjects 
Effect 
Mauchy’s 
W 
Approx. Chi-
Squate df Sig. 
Greenhouse-
Geisser 
Condition 1.000 0.000 0 . 1.000 
Time 0.288 17.076 5 0.004 0.550 
Condition * Time 0.819 2.735 5 0.741 0.898 
 
Source  
Type III Sum 
of Squares df 
Mean 
Square F 
 
Sig 
Time Sphericity Assumed 3.426 3 1.142 2.609 0.063 
 Greenhouse-Geisser 3.426 1.649 2.077 2.609 0.102 
Time x 
Condition 
Sphericity 
Assumed 9.244 3 3.081 7.134 0.001 
 Greenhouse-Geisser 9.244 2.694 3.432 7.134 0.001 
 
Paired T-Tests 
 95% Confidence Interval    
 Mean Lower Upper T df Sig. (2-tailed) 
Pre-RA – Pre-AR 0.000 -0.547 0.457 0.000 16 1.000 
Mid-RA – Mid-AR -0.694 -1.196 -0.192 -2.932 16 0.010 
P10-RA – P10-AR 0.741 0.242 1.240 3.148 16 0.006 
P30-RA – P30-AR 0.125 0.289 0.740 0.433 15 0.671 
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B.3 Central Pulse Wave Velocity 
Repeated Measures ANOVA 
 
Within Subjects 
Effect 
Mauchy’s 
W 
Approx. Chi-
Squate df Sig. 
Greenhouse-
Geisser 
Condition 1.00 0.000 0 . 1.000 
Time 0.292 18.114 5 0.003 0.619 
Condition * Time 0.543 8.985 5 0.110 0.765 
 
Source  
Type III Sum 
of Squares df 
Mean 
Square F 
 
Sig 
Time Sphericity Assumed 3.700 3 1.233 4.975 0.061 
 Greenhouse-Geisser 3.700 1.858 1.991 4.975 0.061 
Time x 
Condition 
Sphericity 
Assumed 0.757 3 0.252 1.123 0.237 
 Greenhouse-Geisser 0.757 2.294 0.330 1.123 0.237 
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B.4 Normalized Central Pulse Wave Velocity 
Repeated Measures ANOVA 
 
Within Subjects 
Effect 
Mauchy’s 
W 
Approx. Chi-
Squate df Sig. 
Greenhouse-
Geisser 
Condition 1.00 1.000 0 . 1.000 
Time 0.292 0.450 5 0.072 0.714 
Condition * Time 0.543 0.770 5 0.651 0.883 
 
Source  
Type III Sum 
of Squares df 
Mean 
Square F 
 
Sig 
Time Sphericity Assumed 0.001 3 0.000 2.617 0.063 
 Greenhouse-Geisser 0.001 2.143 0.000 2.617 0.083 
Time x 
Condition 
Sphericity 
Assumed 0.001 3 0.000 7.424 0.000 
 Greenhouse-Geisser 0.001 2.649 0.000 7.424 0.001 
 
Paired T-Tests 
 95% Confidence Interval    
 Mean Lower Upper T df Sig. (2-tailed) 
Pre-RA – Pre-AR 0.002 -0.005 0.009 0.688 16 0.502 
Mid-RA – Mid-AR 0.009 0.004 0.014 4.099 15 0.001 
P10-RA – P10-AR -0.008 -0.014 -0.001 -2.616 15 0.019 
P30-RA – P30-AR -0.007 -0.013 -0.001 -2.322 15 0.035 
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Appendix C. Raw Data for Study 2 
C.1 Demographic Information 
 
Group Subject # Sex Age 
Height 
(cm) 
Mass 
(kg) BMI 
Body Fat 
(%) 
Ec
ce
nt
ric
 
1 M 31 169 69.6 24.4 17.0 
2 M 22 174 76.8 25.4 15.6 
3 F 21 164 60.9 22.6 29.6 
4 F 21 159.5 73.2 28.8 48.4 
5 M 25 179.5 69.2 21.5 8.2 
6 F 22 165.1 60.3 22.1 33.2 
7 M 20 183 75.6 22.6 18.6 
8 M 20 182 106.9 32.3 37.6 
9 M 20 191.5 70.3 19.2 16.5 
10 M 26 177 79.8 25.5 8.9 
11 M 24 172.2 71.1 24.0 8.0 
C
on
ce
nt
ric
 
12 F 23 158.5 49.3 19.6 20.5 
13 M 25 184 79.8 23.6 11.0 
14 M 22 186.5 92.1 26.5 19.0 
15 F 21 177 111.0 35.4 48.3 
16 M 21 173 75.9 25.4 32.9 
17 M 21 169.5 81.5 28.4 41.6 
18 M 27 186.5 81.6 23.5 28.9 
19 M 24 169 70.8 24.8 30.4 
20 M 23 197 93.6 24.1 11.0 
21 M 23 172.7 66.4 22.3 12.2 
22 M 32 169.0 71.0 24.9 17.0 
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C.2 Brachial Hemodynamics: Pre-Exercise 
 
Group Subject SAP DAP MAP HR 
Ec
ce
nt
ric
 
1 105 56 72 49 
2 125 57 80 81 
3 94 58 70 57 
4 . . . . 
5 116 58 77 47 
6 98 53 68 65 
7 113 56 75 66 
8 121 75 90 72 
9 116 61 79 62 
10 106 62 77 79 
11 107 55 72 56 
12 131 78 96 54 
13 99 49 61 64 
C
on
ce
nt
ric
 
14 99 54 69 56 
15 114 53 73 62 
16 128 67 87 42 
17 102 61 75 74 
18 97 55 69 53 
19 114 76 89 70 
20 120 60 80 64 
21 108 65 79 65 
22 118 51 73 59 
23 113.0 58.0 76 60 
24 111.0 67.0 82 56 
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C.3 Brachial Hemodynamics: 10 min Post-Exercise 
 
Group Subject SAP DAP MAP HR 
Ec
ce
nt
ric
 
1 118 62 81 56 
2 127 55 79 75 
3 99 52 68 68 
4 . . . . 
5 117 49 72 62 
6 107 57 74 75 
7 116 54 75 75 
8 122 68 86 73 
9 114 50 71 59 
10 114 56 75 81 
11 107 53 71 59 
12 129 70 90 50 
13 107 49 68 77 
C
on
ce
nt
ric
 
14 106 48 67 74 
15 108 43 65 79 
16 119 46 70 45 
17 116 62 80 79 
18 100 53 69 59 
19 114 62 79 74 
20 117 52 74 79 
21 119 58 78 89 
22 112 43 66 69 
23 115.0 49.0 71 67 
24 113.0 57.0 76 72 
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C.4 Brachial Hemodynamics: 30 min Post-Exercise 
 
Group Subject SAP DAP MAP HR 
Ec
ce
nt
ric
 
1 105 55 71 50 
2 126 53 77 69 
3 102 58 73 60 
4 . . . . 
5 . . . . 
6 109 61 77 63 
7 113 52 72 64 
8 121 71 88 69 
9 109 58 75 54 
10 109 57 74 68 
11 104 52 69 53 
12 129 66 87 51 
13 99 48 65 73 
C
on
ce
nt
ric
 
14 102 52 64 69 
15 107 50 69 72 
16 123 52 76 45 
17 116 60 79 79 
18 98 63 75 57 
19 113 68 83 67 
20 123 53 76 71 
21 128 63 85 76 
22 116 40 65 65 
23 113.0 50.0 71 61 
24 111.0 56.0 74 65 
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C.5 Pulse Wave Analysis Trial 1: Pre-Exercise 
 
    OI HR aSAP aDAP aMAP aPP AIx AIx@75 
Ec
ce
nt
ric
 
1 91 52 88 57 72 31 -3 -14 
2 99 79 97 58 74 39 -11 -9 
3 92 59 81 58 68 23 -1 -8 
4 . . . . . . . . 
5 85 49 90 58 70 32 -21 -33 
6 88 56 82 53 66 29 -5 -14 
7 82 59 93 56 71 37 11 3 
8 89 78 103 76 89 27 4 5 
9 99 64 96 61 76 35 -8 -13 
10 91 72 87 63 74 24 4 3 
11 98 58 86 55 69 31 -11 -19 
12 96 54 109 78 91 31 -11 -22 
13 90 61 79 49 61 30 -15 -22 
C
on
ce
nt
ric
 
14 100 57 80 54 67 26 -3 -11 
15 94 60 90 54 66 36 -26 -33 
16 100 40 103 67 81 36 -12 -29 
17 96 72 85 61 70 24 -16 -18 
18 88 56 80 55 66 25 -5 -14 
19 82 70 99 77 87 22 6 4 
20 100 63 96 60 74 36 -26 -31 
21 87 70 94 66 80 28 10 8 
22 95 61 91 51 65 40 -11 -17 
23 100 54 93 59 75 34 2 -8 
24 88 56 95 68 82 27 7 -2 
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C.6 Pulse Wave Analysis Trial 1: 10 min Post-Exercise 
 
    OI HR aSAP aDAP aMAP aPP AIx AIx@75 
Ec
ce
nt
ric
 
1 97 65 101 63 81 38 11 6 
2 89 83 96 56 75 40 -4 0 
3 98 67 80 53 66 27 -2 -6 
4 . . . . . . . . 
5 75 60 90 50 69 40 4 -4 
6 89 72 91 58 73 33 15 13 
7 77 72 98 56 76 42 7 6 
8 83 78 104 69 87 35 8 7 
9 93 60 92 50 68 42 -1 -8 
10 94 78 94 58 74 36 4 6 
11 92 61 88 53 69 35 6 -1 
12 100 53 106 71 86 35 -11 -21 
13 98 82 86 52 67 61 -4 -1 
C
on
ce
nt
ric
 
14 91 71 81 48 63 33 -1 -3 
15 100 79 81 46 60 35 -9 -7 
16 97 48 89 46 63 43 -9 -22 
17 86 75 94 63 76 31 -1 -1 
18 84 65 80 53 64 27 -7 -12 
19 91 73 92 63 79 29 0 -1 
20 100 72 90 53 69 37 -19 -20 
21 100 66 94 58 75 36 1 -3 
22 78 72 89 45 62 44 -5 -7 
23 86 64 93 50 71 43 3 -3 
24 94 69 93 58 75 35 5 2 
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C.7 Pulse Wave Analysis Trial 1: 30 min Post-Exercise 
 
    OI HR aSAP aDAP aMAP aPP AIx AIx@75 
Ec
ce
nt
ric
 
1 99 56 88 56 71 32 6 -3 
2 97 75 96 54 73 42 -7 -7 
3 86 56 84 58 70 26 -4 -13 
4 . . . . . . . . 
5 . . . . . . . . 
6 95 60 92 61 75 31 14 7 
7 77 66 89 52 67 37 -4 -8 
8 92 71 103 72 87 31 8 6 
9 92 59 90 58 70 32 -8 -15 
10 89 71 92 58 73 34 8 6 
11 95 50 84 53 66 31 1 -11 
12 96 49 103 67 82 36 -11 -23 
13 98 77 80 50 62 30 -7 -6 
C
on
ce
nt
ric
 
14 97 65 80 51 64 29 -5 -10 
15 86 67 81 43 58 38 -15 -18 
16 100 44 93 51 67 42 -10 -25 
17 97 83 92 62 76 30 -7 -2 
18 88 54 83 63 71 20 -9 -19 
19 83 59 93 68 80 25 -5 -12 
20 97 76 92 54 70 38 -13 -12 
21 85 72 105 64 83 41 11 9 
22 100 57 87 40 57 47 -11 -20 
23 95 54 89 51 69 38 -2 -12 
24 98 62 59 57 71 32 -5 -11 
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C.8 Pulse Wave Analysis Trial 2: Pre-Exercise 
 
    OI aSAP aDAP aMAP aPP aSAP AIx AIx@75 
Ec
ce
nt
ric
 
1 96 52 88 57 71 31 -4 -15 
2 99 76 97 58 76 39 -5 -5 
3 77 57 81 58 68 23 7 -1 
4 . . . . . . . . 
5 82 48 91 58 72 33 -8 -21 
6 84 57 82 54 66 28 -3 -12 
7 93 60 94 57 72 37 14 7 
8 87 66 105 76 89 29 10 6 
9 99 62 94 61 74 33 -9 -15 
10 83 75 88 63 74 25 9 9 
11 83 54 86 56 69 30 -9 -19 
12 98 53 108 79 91 29 -5 -16 
13 92 65 80 49 62 31 -14 -19 
C
on
ce
nt
ric
 
14 89 55 80 84 67 26 1 -9 
15 92 60 91 53 66 38 -25 -32 
16 92 44 102 67 80 35 -12 -26 
17 95 69 85 61 70 24 -14 -17 
18 88 57 80 55 67 25 -5 -13 
19 91 66 100 76 88 24 9 4 
20 100 63 95 61 73 34 -27 -33 
21 83 68 94 66 79 28 12 9 
22 92 59 92 51 67 41 -8 -15 
23 90 58 92 59 76 33 0 -9 
24 96 57 95 68 82 27 6 -2 
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C.9 Pulse Wave Analysis Trial 2: 10 min Post-Exercise 
 
    OI HR aSAP aDAP aMAP aPP AIx AIx@75 
Ec
ce
nt
ric
 
1 91 63 101 63 82 38 11 6 
2 94 80 96 56 74 40 -4 -2 
3 78 69 80 52 67 28 -2 -5 
4 . . . . . . . . 
5 76 53 94 50 70 44 12 2 
6 85 69 90 58 73 32 15 12 
7 79 73 98 57 76 41 8 7 
8 87 73 103 69 87 34 10 9 
9 98 61 92 50 67 42 -5 -13 
10 86 77 94 57 73 37 -3 -2 
11 80 59 88 53 68 35 6 -2 
12 100 55 105 71 86 34 -8 -18 
13 95 78 87 51 67 36 -2 -1 
C
on
ce
nt
ric
 
14 96 66 81 48 64 33 -1 -3 
15 89 73 81 44 59 37 -7 -8 
16 86 51 92 47 66 46 -5 -17 
17 97 83 92 62 76 30 -7 -2 
18 95 59 80 53 65 27 -4 -12 
19 77 72 92 63 79 29 -2 -3 
20 100 75 90 53 69 37 -9 -9 
21 99 69 93 59 74 34 -1 -4 
22 100 72 89 45 62 44 -3 -4 
23 96 64 94 50 70 44 2 -3 
24 89 69 93 58 75 35 6 4 
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C.10 Pulse Wave Analysis Trial 2: 30 min Post-Exercise 
 
    OI HR aSAP aDAP aMAP aPP AIx AIx@75 
Ec
ce
nt
ric
 
1 89 59 87 56 70 31 4 -4 
2 88 70 96 54 71 42 -8 -10 
3 . . . . . . . . 
4 . . . . . . . . 
5 . . . . . . . . 
6 87 63 84 62 78 32 20 14 
7 90 61 90 52 67 38 -4 -11 
8 83 66 102 72 87 30 8 4 
9 94 58 90 58 70 32 -9 -17 
10 93 68 92 59 74 33 8 5 
11 86 59 84 52 65 32 -1 -9 
12 99 53 103 67 83 36 -8 -19 
13 88 72 82 49 64 33 -3 -4 
C
on
ce
nt
ric
 
14 98 65 80 52 64 28 -9 -13 
15 99 67 81 43 58 38 -14 -18 
16 100 46 93 52 68 41 -10 -24 
17 90 76 92 60 73 32 -7 -7 
18 95 56 83 63 72 20 -8 -18 
19 84 62 94 68 80 26 -7 -14 
20 94 69 93 54 71 39 -10 -13 
21 . . . . . . . . 
22 100 60 86 41 58 45 -9 -16 
23 98 62 88 51 70 37 -1 -7 
24 100 62 59 57 72 32 -2 -8 
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C.11 Pulse Wave Velocity: Pre-Exercise 
 
  Peripheral PWV Central PWV  
  Trial 1 Trial 2 Trial 1 Trial 2 
  Velocity SD Velocity SD Velocity SD Velocity SD 
Ec
ce
nt
ric
 
1 6.3 0.3 5.7 0.4 5.3 0.2 5.5 0.3 
2 7.6 0.6 8.2 0.6 8.1 0.6 7.7 0.6 
3 7.6 0.5 7.2 0.7 5.6 0.2 5.1 0.3 
4 . . . . . . . . 
5 . . 5.8 0.6 4.9 0.5 5.4 0.6 
6 8.4 1.2 9.7 1.4 5.7 0.6 5.0 0.3 
7 4.9 0.4 5.9 0.3 5.1 0.3 5.8 0.4 
8 7.4 0.6 7.7 0.8 5.6 0.3 5.9 0.4 
9 6.7 0.5 6.5 0.6 5.9 0.5 5.3 0.4 
10 6.4 0.4 7.3 0.4 6.3 0.6 6.1 0.3 
11 7.5 0.2 7.2 0.3 6.9 0.3 5.8 0.2 
12 7.5 0.5 8.1 0.3 6.8 0.3 6.8 0.6 
13 6.1 0.6 6.8 0.6 4.7 0.5 5.2 0.5 
C
on
ce
nt
ric
 
14 8.0 0.7 6.5 0.4 5.0 0.3 5.1 0.4 
15 6.0 0.3 5.5 0.3 5.5 0.6 4.9 0.1 
16 5.9 0.4 7.2 0.2 5.3 0.3 5.0 0.4 
17 6.9 0.3 5.6 0.2 6.3 0.5 . . 
18 7.4 0.4 7.9 0.8 5.1 0.4 5.8 0.5 
19 8.5 0.9 7.3 0.7 5.4 0.4 5.4 0.3 
20 6.8 0.4 6.1 0.2 5.5 0.3 5.7 0.3 
21 8.3 0.4 8.2 0.7 7.1 0.5 7.3 0.7 
22 5.8 0.3 6.2 0.5 6.1 0.5 5.0 0.5 
23 6.8 0.3 7.1 0.3 4.8 0.2 5.7 0.3 
24 7.70 0.70 7.00 0.40 5.40 0.4 5.9 0.4 
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C.12 Pulse Wave Velocity: 10 min Post-Exercise 
 
  Peripheral PWV Central PWV  
  Trial 1 Trial 2 Trial 1 Trial 2 
  Velocity SD Velocity SD Velocity SD Velocity SD 
Ec
ce
nt
ric
 
1 5.8 0.3 6.7 0.5 4.9 0.2 5.8 0.4 
2 6.5 0.2 6.5 0.4 8.3 0.7 6.5 0.4 
3 8.2 0.3 7.4 0.4 . . . . 
4 . . . . . . . . 
5 4.5 0.2 6.4 0.6 . . . . 
6 7.0 0.7 . . 4.8 0.4 4.6 0.3 
7 5.4 0.3 5.9 0.4 7.5 0.6 . . 
8 7.0 0.4 7.2 0.3 6.9 0.6 5.4 0.2 
9 6.6 0.3 6.6 0.5 5.1 0.4 4.8 0.3 
10 6.9 0.2 5.3 0.3 . . . . 
11 7.1 0.4 7.3 0.3 5.9 0.2 6.5 0.3 
12 6.1 0.2 6.4 0.2 5.8 0.4 . . 
13 5.6 0.3 6.0 0.3 6.5 0.4 6.3 0.4 
C
on
ce
nt
ric
 
14 6.5 0.2 6.1 0.3 4.8 0.3 5.5 0.4 
15 5.4 0.2 5.3 0.1 5.4 0.3 5.8 0.3 
16 6.7 0.4 . . 6.2 0.3 5.4 0.3 
17 6.3 0.4 6.6 0.2 6.7 0.3 6.3 0.7 
18 7.0 0.6 . . 6.5 0.5 . . 
19 7.8 0.5 7.3 0.4 5.9 0.3 5.4 0.3 
20 6.5 0.5 7.0 0.5 5.2 0.2 5.3 0.2 
21 8.2 0.3 7.4 0.4 . . . . 
22 5.4 0.3 5.2 0.3 6.1 0.6 6.3 0.5 
23 6.2 0.4 6.8 0.4 5.5 0.2 4.8 0.3 
24 6.0 0.3 6.0 0.2 5.6 0.5 5.4 0.3 
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C.13 Pulse Wave Velocity: 30 min Post-Exercise 
 
  Peripheral PWV Central PWV  
  Trial 1 Trial 2 Trial 1 Trial 2 
  Velocity SD Velocity SD Velocity SD Velocity SD 
Ec
ce
nt
ric
 
1 5.8 0.3 6.7 0.5 4.9 0.2 5.8 0.4 
2 6.5 0.2 6.5 0.4 8.3 0.7 6.5 0.4 
3 8.2 0.3 7.4 0.4 . . . . 
4 . . . . . . . . 
5 4.5 0.2 6.4 0.6 . . . . 
6 7.0 0.7 . . 4.8 0.4 4.6 0.3 
7 5.4 0.3 5.9 0.4 7.5 0.6 . . 
8 7.0 0.4 7.2 0.3 6.9 0.6 5.4 0.2 
9 6.6 0.3 6.6 0.5 5.1 0.4 4.8 0.3 
10 6.9 0.2 5.3 0.3 . . . . 
11 7.1 0.4 7.3 0.3 5.9 0.2 6.5 0.3 
12 6.1 0.2 6.4 0.2 5.8 0.4 . . 
13 5.6 0.3 6.0 0.3 6.5 0.4 6.3 0.4 
C
on
ce
nt
ric
 
14 6.5 0.2 6.1 0.3 4.8 0.3 5.5 0.4 
15 5.4 0.2 5.3 0.1 5.4 0.3 5.8 0.3 
16 6.7 0.4 . . 6.2 0.3 5.4 0.3 
17 6.3 0.4 6.6 0.2 6.7 0.3 6.3 0.7 
18 7.0 0.6 . . 6.5 0.5 . . 
19 7.8 0.5 7.3 0.4 5.9 0.3 5.4 0.3 
20 6.5 0.5 7.0 0.5 5.2 0.2 5.3 0.2 
21 8.2 0.3 7.4 0.4 . . . . 
22 5.4 0.3 5.2 0.3 6.1 0.6 6.3 0.5 
23 6.2 0.4 6.8 0.4 5.5 0.2 4.8 0.3 
24 6.0 0.3 6.0 0.2 5.6 0.5 5.4 0.3 
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Appendix D. Summary Statistics for Study 2 
D.1 Aortic Pulsatile Load 
Repeated Measures ANOVA 
 
Within Subjects 
Effect 
Mauchy’s 
W 
Approx. Chi-
Squate df Sig. 
Greenhouse-
Geisser 
Condition 1.000 0.000 0 . 1.000 
Time 0.970 0.275 2 0.871 0.971 
Condition * Time 0.809 1.912 2 0.384 0.839 
 
Source  
Type III Sum 
of Squares df Mean Square F 
 
Sig 
Time Sphericity Assumed 4992062.394 2 2496031.197 36.026 0.000 
 Greenhouse-Geisser 4992062.394 1.942 2571221.759 36.026 0.000 
Time x 
Condition 
Sphericity 
Assumed 223981.121 2 111990.561 2.121 0.146 
 Greenhouse-Geisser 223981.121 1.679 133423.595 2.121 0.156 
 
Paired T-Tests 
 95% Confidence Interval    
 Mean Lower Upper T df 
Sig.  
(2-tailed) 
Pre-E – P10-E -700.455 -1026.180 -374.730 -4.791 10 0.001 
Pre-E – P30-E -167.636 -314.030 -21.243 -2.551 10 0.029 
P10-E – P30-E 532.818 275.906 789.731 4.621 10 0.001 
Pre-C – P10-C -639.273 -775.377 -503.169 -10.465 10 0.000 
Pre-C – P30-C -378.455 -618.576 -138.333 -3.512 10 0.006 
P10-C – P30-C 260.819 14.095 507.541 2.355 10 0.040 
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D.2 Peripheral Pulse Wave Velocity 
Repeated Measures ANOVA 
 
Within Subjects 
Effect 
Mauchy’s 
W 
Approx. Chi-
Squate df Sig. 
Greenhouse-
Geisser 
Condition 1.000 0.000 0 . 1.000 
Time 0.895 0.995 2 0.608 0.905 
Condition * Time 0.949 0.475 2 0.789 0951 
 
Source  
Type III Sum 
of Squares df 
Mean 
Square F 
 
Sig 
Time Sphericity Assumed 3.082 2 1.541 8.527 0.002 
 Greenhouse-Geisser 3.082 1.810 1.702 8.527 0.003 
Time x 
Condition 
Sphericity 
Assumed 0.048 2 0.024 0.107 0.899 
 Greenhouse-Geisser 0.048 1.902 0.025 0.107 0.890 
 
Paired T-Tests 
 95% Confidence Interval    
 Mean Lower Upper T df Sig. (2-tailed) 
Pre-E – P10-E 0.564 0.006 1.121 2.253 10 0.048 
Pre-E – P30-E 0.118 -0.215 0.451 0.791 10 0.447 
P10-E – P30-E -0.446 -0.905 0.015 -2.158 10 0.056 
Pre-C – P10-C 0.446 0.100 0.791 2.871 10 0.017 
Pre-C – P30-C 0.109 -0.320 0.538 0.567 10 0.583 
P10-C – P30-C -0.336 -0.730 0.057 -1.906 10 0.086 
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D.3 Central Pulse Wave Velocity 
Repeated Measures ANOVA 
 
Within Subjects 
Effect 
Mauchy’s 
W 
Approx. Chi-
Squate df Sig. 
Greenhouse-
Geisser 
Condition 1.000 0.000 0 . 1.000 
Time 0.341 7.530 2 0.023 0.603 
Condition * Time 0.810 1.475 2 0.478 0.840 
 
Source  
Type III Sum 
of Squares df 
Mean 
Square F 
 
Sig 
Time Sphericity Assumed 0.381 2 0.191 0.798 0.467 
 Greenhouse-Geisser 0.381 1.206 0.316 0.798 0.417 
Time x 
Condition 
Sphericity 
Assumed 0.203 2 0.102 0.709 0.507 
 Greenhouse-Geisser 0.203 1.681 0.121 0.709 0.486 
 
  
